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1 
A  Abstract 
Subarachnoid hemorrhage is a subtype of stroke that is caused by a bleeding into the 
subarachnoid space. Cerebral ischemia develops early after the bleeding and has a 
negative influence on outcome in patients. The underlying pathophysiology triggering 
early ischemia has not been characterized in detail. Suggested pathomechnisms are 
pial microvasospasm, endothelial dysfunction and microthrombosis. The aim of the 
current thesis was to characterize and reveal the pathophysiology of microcirculatory 
perfusion deficits early after subarachnoid hemorrhage. The main hypothesis was that 
pericytes constrict upon subarachnoid hemorrhage and thereby induce capillary spasm 
and hamper parenchymal blood flow dynamics. 
 
We found that pial arterioles constrict in three different characteristic patterns and that 
spastic vessel segments were continuously covered with vascular smooth muscle cells. 
Superficial microvasospasm was associated with reduced blood flow velocity and 
significant reduction of endothelial intracellular Ca2+ concentration which may be a 
trigger for endothelial dysfunction. Reduced blood flow velocity in combination with 
reduced vessel diameter diminished total blood volume that reached the parenchymal 
microcirculation via penetrating arterioles. This led to a severe reduction of perfused 
capillary volume in the cortex. Leukocyte numbers that were sticking in capillaries and 
venules were increased after subarachnoid hemorrhage but their numbers were too low 
to explain severe perfusion deficits.  
 
Capillaries revealed a significantly reduced vessel diameter after subarachnoid 
hemorrhage, however vessel narrowings were not co-localizing with sites where 
pericytes were associated to capillaries. Furthermore pericytes neither underwent cell 
death nor migrated away from capillaries within 24 hours after the bleeding. 
 
In conclusion we showed that microvasospasm on the brain surface lead to severe 
perfusion deficits in the parenchyma. Microvasospasm are probably induced by 
vascular smooth muscle cells and are accompanied by reduced intracellular Ca2+ 
concentration in endothelial cells. Pericytes do not play a major role in the 
pathophysiology of early ischemia after subarachnoid hemorrhage: they neither migrate, 
nor die or induce capillary spasm. 
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B  Introduction 
1. Subarachnoid hemorrhage 
1.1. Clinical features 
1.1.1. Epidemiology 
Subarachnoid hemorrhage (SAH) is a rather rare subtype of stroke. In 2005 the annual 
age adjusted incidence in Northern Americans was nine per 100,000.1 With this 
incidence it accounts for about four percent of all stroke cases. However research in the 
field of SAH is urgently needed, as the case fatality rate is high varying between 23 and 
67%.2 21% of patients die within the first day after the bleeding and 16% even before 
submission to hospital; the cumulative case fatality within the first month after the 
bleeding levels at 44%.3 These numbers show that acute mortality after SAH accounts 
for half of the fatal cases and is therefore clinically highly relevant. Regarding the twelve 
month modified Rankin scale the overall clinical outcome of surviving patients is low.4 
As patients suffer from SAH at a relatively young age and during their productive phase 
the socio-economic cost of SAH is highly relevant. In Germany the five-year-cost of 
each SAH patient is 38 300 Euros.5 
 
In 85% of SAH cases a bleeding into the subarachnoid space occurs due to the rupture 
of an aneurysm.6 Aneurysms develop during the course of life and are present in two to 
three percent of healthy 50-year-old persons. The occurrence of aneurysms is 
associated with certain risk factors like a positive family history for SAH or polycystic 
kidney disease.7 An association with atherosclerosis was suspected but could not be 
reproduced in a meta-analysis.7 A connective tissue weakness may lead to a widening 
of cerebral arteries at locations of increased mechanical stress. Saccular vessel 
malformations develop primarily at branching points of the Circle of Willis,8 an arterial 
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vessel ring located at the base of the brain. The wall of aneurysms is thin and thereby 
prone to rupture. Another more benign form of subarachnoid hemorrhage is 
perimesencephalic hemorrhage where the source of bleeding is presumably venous 
and subarachnoid blood is confined to small areas at the base of the brain without 
causing an increase of intracranial pressure (ICP). Hence the prognosis of 
perimesencephalic hemorrhage is much better than that of aneurysmal SAH.9 
1.1.2.  Symptoms 
The cardinal symptom of patients with acute SAH is sudden headache that is described 
by patients as the worst pain of their lifetime. For half of the patients the onset 
headache is instantaneous and associated with exertion.10  Headache is caused by 
irritation of the dura mater by subarachnoid blood and lasts for about two weeks with 
decreasing intensity. Neck stiffness is caused by irritation through blood products in the 
subarachnoid space and occurs within several hours after the bleeding. Another 
common symptom after SAH is depressed consciousness, which can result in coma. It 
may be the cause of an elevated ICP that results in a reduced cerebral perfusion 
pressure (CPP) and hence global cerebral ischemia.11 Focal neurological deficits like 
aphasia or nerve palsy can occur when brain areas around the location of the vessel 
malformation are affected.12 Generalized seizures occur in 7.8% of patients within one 
hour after onset of headache and are a predictor for high disability five weeks after 
SAH.13 Nausea and vomiting is another common but unspecific symptom in SAH 
patients.14 It may be caused by elevated ICP due to the volume effect of extravasated 
blood. A hydrocephalus develops when clotted blood plugs the arachnoid granulation, a 
structure derived from the dura mater which drains the CSF from the subarachnoid 
space into the venous sinus of the brain. Hydrocephalus symptoms range from a 
decline of consciousness to gaze impairment and non-reactive pupils.15 It is a predictor 
for poor outcome twelve months after SAH.16 SAH can be accompanied by retinal 
bleeding (Terson’s syndrome)17 which induces blurred vision. Alterations of the 
electrocardiogram reflect ischemic heart disease and are diagnosed in 90% of SAH 
patients within 24 hours after the bleeding.18 Episodes of cardiac arrest occur in three 
percent of SAH patients and are associated with poor clinical outcome. Mortality of 
patients with cardiac arrest is significantly higher than of those without cardiac arrest.19  
Rebleedings from the ruptured aneurysm occur in 14% of the patients within the first 24 
hours after the bleeding.20  During the first 21 days after the hemorrhage the cumulative 
risk for rebleeding is 39%. Rebleedings are often detrimental for patients and in 78% 
associated with poor outcome.21 Rebleedings manifest in a sudden deterioration of 
clinical symptoms. 
Delayed cerebral ischemia is a secondary event that develops four to 15 days after the 
initial bleeding in 27% of the patients.22 The cumulative risk for delayed cerebral 
ischemia within 21 days after SAH is 34%.23 It manifests in focal neurological deficits 
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and/or depressed consciousness.24 Vessel spasm of big brain supplying arteries are 
held responsible for the occurrence of delayed cerebral ischemia after SAH. 
1.1.3.  Diagnosis 
Subarachnoid blood can be identified in 98.5% of patients within the first six hours after 
the bleeding by computer tomography (CT). Over time subarachnoid blood is cleared 
and therefore not regularly detectable by CT, therefore the sensitivity of SAH diagnosis 
by CT drops to 90% when performed more than six hours after the bleeding.25 False 
positive interpretation of CT scans may occur due to acute brain swelling, when 
congested blood in subarachnoid vessels may be misinterpreted as extravasated 
subarachnoid blood.26 Acute hydrocephalus is diagnosed by ventricle measurement in 
repetitive CT scans. At late investigation time points magnetic resonance tomography 
(MRT) scans more sensitively portray subarachnoid blood. T2 scans reveal a sensitivity 
of 100% and FLAIR scans of 87% in the subacute phase after SAH.27 When 
subarachnoid blood is found in the initial scan an angiography is performed to identify 
the location and size of aneurysm. The exact localization is needed for surgical 
obliteration of the bleeding site. Angiography can either be performed by catheter 
angiography or by CT and MR angiography.28 The gold standard of aneurysm diagnosis 
is digital subtraction angiography as especially small aneurysms are not always 
detected by native imaging techniques.29 A lumbar puncture of cerebrospinal fluid (CSF) 
is necessary for SAH diagnosis in patients with an uncertain CT scan. Only the 
detection of the hemoglobin breakdown product bilirubin in the CSF is conclusive as 
contaminations with hemoglobin occur in ten percent of lumbar punctures.30 Therefore a 
puncture should be performed twelve hours after the onset of symptoms to allow the 
erythrocytes in the CSF to degenerate and form bilirubin.31 
Vessel spasm of big brain supplying arteries and delayed cerebral ischemia can be 
detected by CT or conventional angiography combined with CT perfusion scan.32 
Transcranial Doppler sonography is a non-invasive indirect diagnostic method for 
vessel spasm which determines blood flow velocity in brain supplying arteries, mainly 
the Circle of Willis. Constricted vessel segments show an increased blood flow 
velocity.33 However in the past years it became evident that vessel spasm do not seem 
to be the only cause of delayed cerebral ischemia. In one quarter to one third of delayed 
cerebral infarction in patients the common diagnostic imaging techniques are not able to 
predict infarction.24 On the other hand a subset of patients develops delayed cerebral 
ischemia, which is independent of large artery spasm.34 These numbers indicate that 
the pathophysiology of delayed cerebral ischemia cannot be confined to large vessel 
spasm. Accordingly the diagnosis of delayed cerebral ischemia after SAH needs to be 
adapted. 
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1.1.4. Therapy 
The first treatment measures for SAH patients who arrive at the hospital are general 
intensive care procedures: Patients receive fluid by an intravenous line and the head is 
placed at an elevated position to enhance CSF drainage. Patients are intensively 
monitored for focal deficits and body temperature. Furthermore they are monitored with 
electrocardiography to detect and potentially treat cardiac complications. Extensive 
headache is treated with analgesics to comfort the patient and to keep blood pressure 
below 180 mmHg in order to avoid re-bleedings.35  
The prevention of re-bleedings from the ruptured aneurysm is the primary goal of acute 
treatment after SAH. After identification of the bleeding site the aneurysm is surgically 
treated by clipping or coiling. Traditionally the ruptured aneurysm was obliterated by 
application of a clip at the aneurysm shaft. Therefore the skull has to be opened to 
make the aneurysm accessible for intervention. For coiling a small platinum coil is 
pushed into the aneurysm that triggers clot formation and its obliteration. The wire is 
applied by an endovascular approach36 which makes coiling the less invasive 
technique. The decision which obliteration technique is employed depends on the size, 
shape and location of the aneurysm. An international trial comparing both techniques 
found an absolute risk reduction for poor outcome for coiling versus clipping.37  
Patients who arrive at the hospital with depressed consciousness might suffer of global 
cerebral perfusion deficits due to elevated ICP. A conservative approach to reduce ICP 
is to administer hyperosmotic fluids which cause an osmotic gradient between the 
intravascular space and the brain parenchyma thereby reducing brain water content. In 
patients who do not respond to conservative therapy, an evacuation of the hematoma or 
a hemicraniectomy might be indicated to lower ICP. However a single center matched 
pair analysis between SAH patients that underwent decompressive craniectomy or 
conservative therapy revealed no difference in outcome between both treatments.38  
A hydrocephalus may develop acutely after the hemorrhage due to plugging of the 
subarachnoid space with clotted blood. These clots can be lysed therapeutically by 
intraventricular application of recombinant tissue plasminogen activator.39 
Hydrocephalus resolves after successful clearance of the drainage system. If 
hydrocephalus persists CSF needs to be drained by lumbar puncture or ventricular 
catheterization.35 
In the last decades many clinical trials were conducted in order to identify new drugs for 
the treatment of delayed cerebral ischemia and large vessel spasm: Ca2+ antagonists, 
namely Nimodipine, reduce the absolute risk of poor outcome during delayed cerebral 
ischemia by 5.3%.40 In Germany 91% of surveyed centers use Nimodipine orally for 
prevention and treatment of delayed cerebral ischemia.41 The endothelin-1 receptor 
antagonist Clazosentan significantly resolved angiographic vasospasm,42 however, it 
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did not improve delayed cerebral ischemia and patient outcome.43 Statins are discussed 
to improve vascular reactivity via cholesterol dependent mechanisms and restoration of 
endothelial function.44 Pravastatin was suggested to reduce vasospasm and mortality 
associated to delayed cerebral ischemia.45 However subsequent trials could not confirm 
the protective results of statins after SAH.46, 47 Magnesium sulphate is thought to inhibit 
voltage gated Ca2+ channels thereby reducing contraction of vascular smooth muscle 
cells (VSMC). So far, however, clinical trials investigating the potential effect of 
magnesium after SAH were inconclusive. Thus no proof of a beneficial effect of 
magnesium on delayed cerebral ischemia exists.48 Despite negative or inconclusive 
trails magnesium and statins are commonly used in clinical practice for the treatment of 
cerebral vasospasm due to the lack of alternatives and a reasonable safety profile.41 A 
different therapeutic approach for delayed cerebral ischemia is the so-called triple H 
therapy that aims to facilitate cerebral perfusion by hemodilution, hypervolaemia and 
hypertension.49 However a prospective clinical trial on triple H therapy has never been 
conducted. Potential negative side effects like pulmonary edema or renal dysfunction 
have to be kept in mind when evaluating the triple H therapy.50 In clinical practice a 
targeted mean arterial blood pressure of 90 to 110 mmHg is achieved by administration 
of Norepinephrine and hypervolaemia/hemodilution is achieved by additional 
intravenous fluid administration of one to three liters electrolyte solution per day.41  
Furthermore vessel spasm may be mechanically dilated by angioplasty or balloon 
vasodilatation using an endovascular approach. The endovascular balloon dilatation of 
spastic vessel segments was first described by Zubkov et al.51 The combination of the 
endovascular dilation approach together with local application of vasodilative 
substances shows promising results for the opening of spastic vessel segments. 
However vasodilation by local application of papaverine did not sustain until the next 
day after intervention.52  
In conclusion validated treatment options after SAH are rare. Nimodipine is to date the 
only therapy for delayed cerebral ischemia that proved efficacy in a prospective 
randomized trial. The most striking finding is that Clazosentan resolved vessel spasm 
but does not have a beneficial effect on delayed cerebral ischemia. The result of the 
trial indicates that delayed cerebral ischemia is probably multifactorial and cannot be 
narrowed down to cerebral large artery spasm.53, 54 It implies that large vessel spasm 
might not be the correct therapeutic target for treatment of delayed cerebral ischemia. 
Research on the complex pathophysiology after SAH will have to be performed to 
identify new therapeutic targets.55  
1.2. Animal models 
In the past most experimental SAH studies have been conducted in larger laboratory 
animals such as dogs or rabbits. The double injection dog SAH model was a widely 
used animal model for the investigation of delayed cerebral ischemia and vasospasm.56 
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In the past years large laboratory animal research declined; today most of SAH 
research is performed in rodents like rats and mice.56 Mice have the advantage that 
transgenic animals are available. The design of genetically modified mice offers new 
opportunities for experimental research but also the challenge to adopt microsurgically 
demanding animal models to these rather small rodents. At present a couple of different 
mouse SAH models exist where blood is either injected into the subarachnoid space or 
a subarachnoid vessel is perforated. The SAH blood injection model in rodents was first 
described by Solomon et al.57 Autologous arterial blood withdrawn from a peripheral 
vessel is injected into the cisterna magna. This method is fast and relatively easy to 
perform. Animals develop an increased ICP, neurological deficits and delayed 
vasospasm.58 However, the site of injection does not correspond to the clinical situation 
where bleeding mostly occurs at the Circle of Willis. Therefore another injection model 
has been established where the blood is applied into the prechiasmatic cistern59 which 
corresponds to the usual bleeding site in patients. A drawback of the prechiasmatic 
injection model is that a needle needs to be pushed through the brain in order to reach 
the skull base. The biggest advantages of injection models are that the amount of 
injected blood can be controlled and that the effect of blood can be distinguished from 
the volume effect of saline injection in the sham situation. A drawback of the injection 
model is, however, that a vessel injury/rupture cannot be mimicked. An alternative 
approach for bleeding induction is to perforate a brain-supplying vessel and thereby 
induce a local bleeding. This can be achieved for example by intracisternal vein 
transection technique. A vein at the base of the brain is opened and allows a venous 
blood spill into the subarachnoid space.60 However in the clinical condition SAH is 
mostly caused by an arterial bleeding which reveals a different blood pressure situation 
than veins. The vein transection technique therefore rather mimics the situation of a 
perimesencephalic SAH. In order to model the pathophysiology of an artery rupture the 
endovascular perforation model was developed.61 This model was first described in rats 
by Bederson et al.62 and Veelken et al.63 A stiff filament is inserted into the left external 
carotid artery and advanced to the skull base via the internal carotid artery. At the 
bifurcation of the middle cerebral artery the filament perforates the Circle of Willis which 
initiates blood extravasation into the subarachnoid space.64 This model reflects the 
clinical feature of a vessel injury and can also exhibit rebleedings, which occur in 39% 
of patients within 3 weeks after SAH.21 The endovascular perforation model was 
adapted to mice by Kamii et al.65 and Parra et al.66 Provided that a standardized 
anesthesia protocol is used and ICP and CBF are monitored the mouse endovascular 
perforation model is highly reproducible and suited to investigate early brain injury after 
SAH.67 
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1.3. Pathophysiology 
1.3.1. Delayed brain injury 
Traditionally SAH research was primarily focused on delayed cerebral ischemia rather 
than early pathophysiologic events. Therefore to date most of mechanistic insights and 
therapeutic studies are based on delayed brain injury. Since the first description of large 
vessel constrictions after SAH in 195168 it was believed that artery spasm induce 
delayed cerebral ischemia. Vessel spasm of big brain supplying arteries are mediated 
by contraction of VSMC. Muscle fiber contraction is induced by Ca2+ influx through 
voltage dependent Ca2+ channels and a subsequent increase of the free intracellular 
Ca2+ concentration. Elevated Ca2+ levels initiate phosphorylation of myosin light chains 
and subsequent contraction.69  After SAH contracted cerebral arteries tend to have a 
higher amount of phosphorylated myosin light chain than arteries of controls.70  
Another potential pathomechanism of delayed vessel spasm is that hemoglobin in the 
subarachnoid space scavenges nitric oxide (NO), a potent soluble vasodilator. NO 
which is released from endothelial cells induces relaxation of VSMC via cyclic 
guanylatcyclase signaling.71 When NO is bound by hemoglobin the expression levels of 
soluble cyclic guanylatcyclase is reduced and the endothelium dependent relaxation of 
cerebral vessels is impaired.72 In this context also the production of reactive oxygen 
species after SAH plays a role. The conversion of hemoglobin to oxyhemoglobin 
releases superoxides, which together with NO form peroxynitrite, a neurotoxic 
substance.73 If the free radical scavenging system is therapeutically enhanced by 
induction of the enzyme superoxide dismutase the production of superoxide can be 
diminished and vasospasm can be ameliorated.65 The concept that free radicals play a 
role in the formation of vasospasm is strengthened by a study that shows amelioration 
of vasospasm under treatment with melatonin, a free radical scavenger and stimulator 
of antioxidant enzymes.74  
Endothelin-1 is a potent vasoconstrictive peptide that is found in high concentration in 
the human CSF after SAH.75 Continuous endothelin-1 infusion leads to sustained 
arterial constriction.76 Endothelin-1 is overexpressed in endothelial cells and smooth 
muscle cells during superfusion with oxyhemoglobin and induces arterial narrowing.77 
Neutrophils infiltrating the brain parenchyma after SAH may be a source of increased 
endothelin-1 production.78 Experimental data suggests that vessels become more 
sensitive to endothelin-1 after SAH and are thereby more prone to constrict in its 
presence.79 
However the whole concept that spasm of cerebral arteries induce secondary brain 
infarction after SAH has been challenged by the results of the endothelin-1 antagonist 
Clazosentan trial. Despite successful reopening of the vessels the clinical outcome after 
SAH was not improved.43 This study initiated research and discussion about different 
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mechanisms for the development of delayed brain injury. One proposed alternative 
pathomechanism for large vessel spasm is microthrombosis that induces disturbance of 
the microcirculation and hence delayed cerebral ischemia.80 Recently other 
dysfunctions of the cerebral microcirculation like glial swelling and edema have been 
suggested to be causative for delayed cerebral ischemia.81  
Another potential trigger for delayed cerebral ischemia is cortical spreading depression 
(CSD). It describes a mass depolarization of neurons and glia cells which is initiated by 
a massive efflux of K+ into the extracellular space.82 The cation derangement induces 
enhanced release of the excitatory neurotransmitter glutamate that triggers 
depolarization. The depolarization is self-propagating and induces increased CBF via 
neurovascular coupling in the healthy brain.83 However when brain slices are 
superfused with hemolysis products, cortical depolarization leads to a vasoconstriction 
rather than a vasodilatation.84 This finding initiated studies on CSD in SAH patients. 
Cortical electrical activity, partial pressure of oxygen and CBF were recorded on the 
surface of the cortex after SAH. Spreading depolarization occurred in 12 of 13 patients 
and were in 5 patients associated with local reduction of CBF and hypoxia.85 These 
findings were confirmed by another study in which electrocorticography and oxygen 
pressure measurements were performed during aneurysm clipping.86 The area of 
spreading depolarization co-localized with brain regions that later developed delayed 
cerebral ischemia.87 However CSD alone is not likely to induce cerebral infarction 
because increased neuronal activity induces functional hyperemia in a healthy brain. 
Accordingly, CSD only leads to a relative lack of oxygen and glucose when functional 
hyperemia is impaired.  Another hypothesis is that cortical spreading depression in 
combination with vessel spasm and formation of microemboli induces cerebral 
ischemia.88 
1.3.2. Early brain injury 
Early brain injury describes the pathophysiological changes that occur in the brain 
during the first three days after the bleeding.89 Clinicians and researchers became 
aware that this period is particularly relevant for the pathogenesis of SAH when reversal 
of delayed vasospams with Clazosentan did not result in improvement of delayed 
cerebral ischemia and patient outcome. Therefore pathomechanisms of early brain 
injury have only recently moved into the focus of SAH research. Early brain injury is 
initiated by the impact of bleeding and composed of different key factors: These include 
the rise of ICP and subsequent drop of CPP as well as early cerebral ischemia, 
formation of brain edema, inflammation and neuronal cell death.90  
1.3.2.1. Intracranial pressure 
Upon aneurysm rupture the extravasating blood is filling the subarachnoid cisterns. The 
spill of blood out of the vessel staunches when a blood clot forms at the site of injury. 
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The volume effect of extravasated blood leads to an increase of ICP to values close to 
the systemic blood pressure91 and compresses vessels which are located in the 
subarachnoid space.92 In most cases ICP stabilizes within minutes at values slightly 
above normal. In other cases ICP remains elevated due to formation of a large 
hematoma, development of hydrocephalus or brain edema.93 A mean ICP above 20 
mmHg during the first seven days after the bleeding is associated with high mortality.94 
However the initial peak of ICP seems to be important to stop the bleeding from the 
ruptured aneurysm. A study that investigated ICP during rebleedings in patients under 
early decompressive management shows that these patients show repetitive pressure 
peaks.91 This finding has recently been affirmed by a study on decompressive 
craniectomy in a mouse model of SAH. A craniectomy that is performed before bleeding 
induction mimics initial decompressive management and leads to massive hematoma 
and recurrent bleedings.95  
1.3.2.2.  Acute cerebral ischemia 
Rise of ICP leads to an immediate global reduction of CBF58 because the CPP drops to 
values close to zero.62 This acute and transient cessation of blood flow leads to global 
ischemia as demonstrated by absolute measurements of CBF performed 15 and 90 
minutes after endovascular perforation in rats.96 As global cerebral ischemia is an 
important component of early brain injury after SAH the pathophysiology of both 
diseases overlap.97, 98 Interestingly cerebral perfusion is further diminished even when 
the CPP rises to values close to 70 mmHg several minutes after the bleeding.62 It 
means that the CBF is still disturbed even if ICP drops and the improved CPP 
theoretically allows cerebral reperfusion. These findings indicate that acute cerebral 
ischemia is not only caused by elevated ICP but is multifactorial. Importantly it was 
shown that the reduction of regional CBF 60 min after SAH predicts the 24 hour 
mortality in rats.99 This indicates that acute ischemia after SAH might be one of the key 
predictors in outcome after SAH. Experimental results on early cerebral ischemia are 
also supported by clinical data. In a xenon contrast study it became evident that 
patients suffer of global cerebral ischemia within twelve hours after the insult. Ischemia 
was present in all parts of the brain but brain areas close to the bleeding site were more 
severely affected. Interestingly the extent of ischemia correlated with the clinical score 
of patients indicating that early ischemia plays a significant role in outcome after 
SAH.100, 101 A more recent study investigated the correlation of ischemic lesions depicted 
by MRI within three days after the insult with neurological status, delayed ischemia and 
three-month outcome. Two third of investigated patients show perfusion deficits early 
after the insult. Early ischemia is indeed related with neurological dysfunction, the 
development of delayed ischemia and a poor three-month outcome.102  
Cerebral ischemia after SAH induces a series of pathological events in the brain. These 
include among others cell death, brain edema and inflammation.  
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1.3.2.2.1. Necrosis 
Necrosis describes a cell death pathway that is energy independent. Brain areas that 
are not perfused reveal a severe lack of oxygen and ATP and can therefore not initiate 
programmed cell death.103 Brain pathology samples from patients that died after SAH 
show clusters of necrosis in the cortex.104 Necrotic processes are not only limited to 
neuronal tissue. A rat SAH study revealed that myonecrosis of smooth muscle cells 
occurs 48 hours after the bleeding. Mostly cells of the medial layer next to the elastic 
lamina were affected.58 High mobility group box 1 is a DNA binding protein, which is 
released from necrotic cells and acts as a pro-inflammatory cytokine by activating 
microglia.105 High mobility group box 1 is increased in patients after SAH and correlates 
with poor outcome.106 
1.3.2.2.2. Apoptosis 
Apoptosis is an energy consuming programmed cell death mechanism that is initiated 
by different signaling pathways such as caspases and pro-apoptotic bcl-2 family 
members.107 Some apoptosis related proteins were shown to be enhanced after SAH: 
The concentration of caspase three and eight, cytosolic p53, AIF and cytosolic 
cytochrome C are increased 24 hours after SAH compared to sham condition.108 24 
hours after SAH caspase three and TUNEL positive cells indicate apoptotic processes 
histologically. Apoptosis was primarily shown in endothelial cells and hippocampal 
neurons; only little apoptosis was found in the cerebral cortex.109 The amount of 
apoptotic cells in the hippocampus is higher because hippocampal neurons are more 
sensitive to ischemic conditions than cortical neurons. Endothelial cells are directly 
affected by decreased blood supply and may thereby die first. At ten minutes after SAH 
ten percent of endothelial cells are positive for TUNEL. By 24 hours the number of 
TUNEL positive endothelial cells is reduced to three percent. The time course for 
TUNEL positive neurons shows an opposite pattern with four percent TUNEL positive 
cells at ten minutes and 14% TUNEL positive cells at 24 hours after SAH.110 These data 
implicate that first endothelial cells undergo apoptosis and neurons become apoptotic at 
later time points. The degree of acute cerebral ischemia correlates with the extent of 
apoptosis at two and seven days after SAH. Therefore it is likely that acute rather than 
delayed cerebral ischemia is responsible for apoptotic cell death that is observed after 
SAH.111 
1.3.2.2.3. Metabolic derangement 
A reduction in blood flow induces a metabolic disturbance by impairing the oxidative 
energy metabolism. Primarily in the acute phase of global cerebral ischemia the 
metabolism after SAH is heavily impaired. Oxygen tension is reduced immediately after 
SAH to values around 40% of baseline and only slowly increases during the first 90 
minutes after SAH.96 The extracellular glutamate level raises six-fold within 30 minutes 
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after the insult and is accompanied by a drop of glucose concentration indicating 
increased energy consumption. Additionally lactate concentration, a product of 
anaerobic metabolism is increased 60 minutes after SAH. The increase of lactate levels 
combined with an increase of the lactate pyruvate ratio indicate sustained metabolic 
imbalance.112 This imbalance has further implications for the survival of neurons and 
brain edema formation. 
1.3.2.2.4. Brain edema 
Two different types of brain edema exist: the cytotoxic and vasogenic edema. In the 
cytotoxic form the influx of water into the brain is mediated by swelling of cells as a 
consequence of early global ischemia and metabolic derangement.113 In contrast 
vasogenic edema is caused by a breakdown of the blood brain barrier (BBB).114 
Although both kinds of edema are present after SAH the vasogenic edema seems to 
play the major role. Bovine serum albumin used as a marker of BBB breakdown starts 
extravasating in the ipsilateral hemisphere six hours after the hemorrhage and reaches 
peak values after 48 hours.115 Apoptosis of endothelial cells leads to a leakage of fluid 
and small molecules into the brain parenchyma.109 Microvascular collagenase activity is 
increased at three, six and 24 hours after SAH and returns to baseline levels at 48 
hours after the bleeding.116 One day after the bleeding immunostaining and western blot 
reveal a reduction of collagen VI, a component of the basal lamina.115 Collagen VI is 
also degraded by matrix metalloproteinases (MMP), a proteinase family that is 
modulating the extracellular matrix.117 In MMP 9 knockout mice formation of brain 
edema is reduced compared to wildtype controls, indicating that MMP 9 is contributing 
to microvascular damage after SAH.118 Importantly the extent of brain edema 
development correlates with the clinical outcome119 indicating that brain edema plays an 
important role in the early pathophysiology after SAH. 
1.3.2.2.5. Inflammation 
Inflammatory processes after SAH are induced in patients and manifest in increased 
levels of pro-inflammatory cytokines in the CSF:120 Tumor necrosis factor α (TNFα) is a 
proinflammatory cytokine that is upregulated after SAH.120 It initiates immune cell 
trafficking and the release of other proinflammatory cytokines. The inhibition of TNFα by 
application of a specific antibody after SAH reduces apoptosis.121 Interleukin 6 is 
another proinflammatory cytokine that is secreted in the CSF up to 10,000 fold after 
SAH compared to healthy controls.120 Importantly the regional upregulation of 
proinflammatory cytokines in the brain corresponds with areas of enhanced apoptosis 
after SAH.122  
SAH animal models reveal that macrophages and leukocytes accumulate in the 
subarachnoid space after the bleeding. Macrophages are significantly increased in the 
subarachnoid space from day two to seven compared to sham. T cells are found in 
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significantly higher numbers from day one to three after the bleeding.123 Infiltrating 
immune cells most probably clear extravasated blood and its degradation products.58 
Leukocytes do not only infiltrate the subarachnoid space but also accumulate close to 
cerebral vessels and in the brain parenchyma. Significant numbers of leukocytes 
adhere to the endothelium and start infiltrating into the brain already ten minutes after 
the bleeding; thereafter the total number of adherent and infiltrating leukocytes 
decreases.124 These findings indicate that inflammatory processes are induced 
immediately after SAH. 
Beside immune cell infiltration into the brain SAH may induce a systemic inflammatory 
response syndrome. A systemic inflammatory response is associated with high mortality 
and morbidity in SAH patients.125  
1.4. Microcirculation 
Big brain supplying arteries do not show vessel spasm in the early phase after SAH, 
therefore early cerebral ischemia is probably occurring on the level of the cerebral 
microcirculation. Few studies on the microcirculation after SAH have already been 
performed in the 70ies. A severe bleeding led to a complete non-perfusion of the 
parenchymal microcirculation three hours after the insult in a dog SAH model.126 The 
no-reflow phenomenon was believed to be caused by obstructions of the vessel lumen 
e.g. plugging with microthrombi or leukocytes.127 Obstruction of the capillary lumen may 
also occur when the blood flow velocity drops below a certain threshold that increases 
blood viscosity and thereby leads to obstruction and microthrombosis.128 Furthermore it 
was shown that a local superfusion with blood constricts pial vessels.129 Therefore it is 
likely that subarachnoid vessels that come into direct contract with extravasated blood 
will constrict acutely.  
However the focus of clinical research was always more on large artery spasm. The 
reason for this may be that the microvasculature cannot be depicted with clinical 
imaging techniques. Thus investigations of microvascular changes in patients are 
difficult to perform. Only when early brain injury and especially early cerebral ischemia 
after SAH moved into the focus of research the microcirculation could no longer be 
ignored.  
New imaging techniques like two-photon microscopy with its deep penetration depth 
now make investigations of small vessels possible. With this technique blood flow and 
perfusion parameters can be investigated in detail. The importance of small vessels, 
which supply most of the parenchyma with blood becomes evident in in vivo studies on 
CBF. The occlusion or a hemorrhage of small vessels was modeled in vivo and 
revealed interesting insights on the pathomechanism of neuronal damage.130 Special 
attention has to be drawn to penetrating arterioles because they represent a bottleneck 
in blood supply to superficial layers of the cortex.131 With these tools in hand the 
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hemodynamic impact of superficial vessel pathology on the cerebral microcirculation 
can be investigated in detail.  
Disturbances of blood flow in the microcirculation can either be induced by endothelial 
dysfunction, platelet and leukocyte adhesion or by an active constriction of vessels.  
1.4.1. Endothelial dysfunction 
Endothelial cells coat the inner vessel lumen and thereby come into direct contact with 
blood components. Hence endothelial cells are directly affected by disruption of CBF 
after SAH. Especially the basal lamina of parenchymal microvessels is affected early 
after SAH. When collagen VI is stained in capillaries 24 hours after SAH a decrease of 
area and length of stained vessels can be observed.132 The disruption of the basal 
lamina seems to be induced by reduced blood flow in the capillaries. One suggested 
pathomechanism causing decreased microvascular perfusion after SAH is a lack of the 
vasodilator NO.133 An experimental study of cortical perfusion in rabbits shows that an 
increase of the mean blood transit time correlates with decreased plasma NO levels. 
NO substitution has been shown to be beneficial for brain perfusion as early as one day 
after the bleeding.134 These findings are supported by a study where an NO donor is 
applied systemically directly after the bleeding. Application of an NO donor leads to a 
significant increase in regional CBF compared to a saline treated control.135 Hence early 
NO depletion in the vasculature is a potential pathomechanism of acute cerebral 
ischemia. NO concentration may be reduced after SAH because free hemoglobin in the 
subarachnoid space scavenges NO.136 A lack of NO comes together with reduced 
expression levels of soluble cyclic guanylatcylase, which mediates the endothelium 
dependent relaxation of cerebral microvessels.137 These findings strengthen the role of 
NO for endothelial survival and function after SAH. 
1.4.2. Platelet aggregation 
Blood platelets form aggregates when blood flow velocity is reduced below a certain 
threshold. Aggregates may trigger thrombosis and induce endothelial damage138 as well 
as scattered ischemia.139 Platelet aggregates in the microcirculation occur as early as 
ten minutes after the bleeding and show a biphasic occurrence. Platelet aggregation 
diminishes from one hour to six hours after SAH and peaks again at 24 hours after 
SAH. At 48 hours after SAH no more platelet aggregation is detectable.140 It has also 
been shown that platelet aggregates co-localize with constricted vessel segments, 
regional loss of collagen VI and extravasation ten minutes after SAH. These findings 
indicate that platelet aggregates contribute to endothelial and BBB dysfunction after 
SAH.141 Importantly the number of microthrombi correlates with the number of apoptotic 
cells in the cortex, indicating that microthrombi formation is relevant for neuronal cell 
death.139  
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1.4.3. Leukocyte-endothelium interaction 
After SAH the expression of endothelial adhesion molecules is enhanced. 48 hours 
after the bleeding the protein levels of toll-like receptor 4, nuclear factor kappa b and 
intracellular adhesion molecule-1 are significantly upregulated.142 Adhesion molecules 
mediate rolling and sticking of leukocytes to the endothelium before they transmigrate 
into the parenchyma. The number of adherent and rolling leukocytes was increased 
significantly at eight hours after the bleeding.143 When leukocytes stick in the capillaries 
they may obstruct the vessel lumen and thereby reduce CBF. This no-reflow 
phenomenon was described in global and focal cerebral ischemia.127 Whether 
parenchymal capillaries are similarly plugged by activated leukocytes after SAH has 
never been investigated in vivo. 
1.4.4. Neurovascular coupling 
Neurovascular coupling (NVC) describes the adaptation of blood flow to the metabolic 
needs of neuronal tissue. Activated neurons give metabolic signals via astrocytes to 
VSMC that are located around penetrating arterioles. Long known metabolic signals are 
for example glutamate for vasodilation and ATP and O2 for vasoconstriction. 
Subsequently vessels dilate in case of high-energy demand and constrict when energy 
consumption is low.144 Neural activity also induces Ca2+ dependent release of 
vasodilatory substances at the neurovascular unit.144 One vasodilatory pathway is 
mediated by large conductance Ca2+ waves which activate K+ channels on astrocytic 
endfeet. The increased extracellular K+ concentration leads to vasodilation.145 After SAH 
however this mechanism is inverted, so that an increased extracellular K+ concentration 
induces vasoconstriction instead of vasodilation.146 An inversion of NVC is important for 
the pathophysiology of SAH because an already existing metabolic derangement may 
be further aggravated. 
1.4.5. Microvasospasm 
The term microvasospasm describes a vessel narrowing in superficial cerebral arteries 
that are located within the subarachnoid space. These characteristic vessel spasm were 
first described in human patients that underwent aneurysm clipping within three days 
after the bleeding by orthogonal polarization spectral imaging.147 Microvasospasm occur 
in 50% of superficial arteries and exhibit a mean vessel diameter reduction of 30%. 
Simultaneously the pial capillary density after SAH is reduced significantly.147 Another 
study in patients using the same imaging technique confirmed the initial findings. In this 
study the vessel reactivity during hyperventilation of the patient was observed. In 60% 
of patients the vessels contracted in a pearl-string fashion, which were irresponsive to 
the endogenous vasodilator CO2.148 Similar vasoconstrictions of superficial arteries 
could be reproduced in a rat cisterna magna injection model. Spasm of pial arterioles as 
well as a reduction of venular vessel diameter were described. The microvascular 
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alterations occured in combination with decreased blood flow velocity.149 
Microvasospasm was also found in the mouse endovascular perforation model. Spastic 
arterioles were detected as early as three hours after the hemorrhage and vessels 
stayed spastic up to three days after the bleeding. The spasm was more severe at early 
time points and in smaller vessels. Furthermore microthrombi were found exclusively in 
vessels that were spastic.150 Interestingly these microvasospasm were not reactive to 
hyper- or hypoventilation. The vasodilatory and hyperemic effect of CO2 is not present 
in vessels that exhibit spasms.151  
The hemodynamic consequences of superficial microvasospasm for parenchymal 
perfusion have not been investigated to date. However one may assume that a vessel 
narrowing of superficial brain supplying arteries will impact blood flow in parenchymal 
capillaries. Therefore one aim of the thesis was to characterize microcirculatory 
disturbance that emerges from superficial microvasospasm after SAH.  
In addition the question arises whether also parenchymal vessels constrict in response 
to SAH. Parenchymal capillaries are the vessel segments where metabolites cross the 
BBB and are therefore functionally highly relevant. They have to date not been studied 
in vivo after SAH. Therefore we aimed to investigate whether capillaries in the brain 
parenchyma constrict after SAH and which cell type might mediate vessel narrowing. 
2. Pericytes 
2.1. Characterization 
2.1.1. Morphology 
Pericytes were first described in 1873 by Rouget as contractile cells surrounding 
capillary endothelial cells. The former definition could not sustain until today because 
newer insights revealed that different cell types surround the capillary endothelium.152 
The current morphological definition of a pericyte is a cell that is embedded within the 
vascular basement membrane.153 Accordingly pericytes are completely surrounded by 
the basement membrane with one layer towards endothelial cells and one layer as a 
demarcation to astrocytic endfeet and the perivascular space.154 Pericytes belong to the 
vascular wall154 and are found in the capillary bed of the whole body. The number of 
pericytes is highest in retina and brain, followed by lung tissue.155 In the brain pericytes 
cover up to 30% of the capillary surface.156 Three different subtypes of pericytes were 
distinguished by Zimmermann in 1923:157 Type I is found at the so-called middle 
capillaries. Cells have an elongated cell body with long primary processes that stretch 
along the vessel. One pericyte can span two to four endothelial cells.158 From the 
processes small secondary finger-like branches wrap around the capillary and stretch to 
neighboring pericytes. Processes can overlap and form several layers or contact 
neighboring capillaries.158 Type II pericytes cover precapillary arterioles. They have 
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rather big processes that cover the vessel almost completely. Type III pericytes exhibit a 
big cell body and short processes and are located along postcapillary venules.  
 
2.1.2. Immunohistochemical characterization 
The characterization of pericytes and their discrimination to other perivascular cell types 
is not always easy. The current definition of a pericyte is based on its location and 
morphology: a pericyte is a cell that surrounds the endothelium and is located within the 
same basement membrane.153 A practical problem emerges from this definition: This 
morphological feature can only be seen by electron microscopy, a technique that is not 
always available. A drawback of electron microscopy is that only a tiny tissue area can 
be visualized. Furthermore tissue needs to be treated massively, which makes stainings 
hardly possible. In order to overcome this issue many immunohistochemical markers for 
pericytes have been identified. Unfortunately none of the markers is specific for 
pericytes or stably expressed in the different pericyte subtypes. Hence always a 
combination of different markers has to be considered and combined with 
morphological examinations to allow a statement about the cell type investigated.159 The 
discrimination to endothelial cells can easily be made because pericytes are negative 
for van Willebrand factor and platelet endothelial cell adhesion molecule (PECAM-1), 
both commonly used antigens for endothelium staining.160 Neurons can be 
distinguished morphologically, by location and by staining for specify neuronal markers 
like NeuN (neural nuclei). Challenging is the discrimination of VSMC and pericytes 
because both cell types are suspected to emerge from the same progenitors. In a 
vessel-remodeling situation and in cell culture pericytes can become VSMC and VSMC 
in turn can differentiate into pericytes.161 Precapillary arteriolar and postcapillary venular 
pericytes robustly express the contractile element αSMA which is a commonly used 
marker for VSMC and exhibit contractile functions.162 Neural-glial antigen 2 (NG2), a 
membrane spanning chondroitin sulfate proteoglycan is expressed by capillary 
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pericytes163 and by VSMC in the periphery.164 The intermediate filament protein desmin 
is expressed in VSMC and pericytes.161 A discrimination between pericytes and VSMC 
is therefore primarily possible by their location, as VSMC are located outside the 
basement membrane and separated from the endothelium by an additional layer of 
mesenchymal cells.165 Another challenging discrimination is between pericytes and 
fibroblasts. A useful marker for the identification of brain pericytes is platelet derived 
growth factor receptor β (PDGF Rβ), which is expressed by pericytes. No expression of 
PDGF Rβ was found in neurons, astrocytes or endothelium.166 However mesenchymal 
stem cells and myofibroblasts express PDGF Rβ.167 In conclusion, none of the 
discussed markers is specific and thus always a combination of different markers has to 
be used to identify pericytes.168  
2.1.3. Pericytes within the neurovascular unit 
The neurovascular unit (NVU) is composed of endothelial cells, pericytes and 
astrocytes. The term already implies that cells of the NVU exhibit intense crosstalk and 
are interdependent in several functions.  
Endothelial cells are spindle shaped cells that coat the vessel lumen. They form the 
BBB, a stringently selective barrier between brain vessels and the brain parenchyma. 
The BBB is formed by extensive tight junctions between endothelial cells which are 
composed of cadherins, claudins, occludin and junctional adhesion molecules.169 The 
endothelium is absent of fenestrations in most parts of the brain, therefore nutrients and 
other metabolites have to be transported actively by transporters and endocytosis.170 
The choroid plexus and circumventricular organs however have fenestrated 
endothelium which is more permeable. 
Pericytes are closely attached to endothelial cells. Gap junctions171, adhesion plaques 
and peg-and-socket junctions ensure a tight connection between endothelial cells and 
pericytes. These connections are composed of extracellular matrix proteins like 
fibronectin.153 The active contribution of pericytes in the formation of a functional BBB 
has long been neglected. An in vitro study shows that pericytes induce the expression 
of basement membrane proteins in endothelial cells.172 Studies on pericyte-deficient 
mouse strains reveal the crucial role of pericytes in the formation and regulation of the 
BBB. Heterozygous PDGF Rβ knockout mice exhibit a leakage of the BBB for 
molecules up to 500.000 kD size. It means that in pericyte deficiency molecules like 
fibrin and thrombin can migrate into the brain and accumulate there.173 Another study 
investigating the underlying mechanism of BBB leakage finds an alteration of 
endothelial gene expression patterns and enhanced transcytosis in pericyte deficient 
mice.174 Furthermore pericytes are actively forming the basement membrane by 
synthesizing collagen VI, laminin and glycosaminoglycans.154 
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Pericytes and endothelial cells are coated by astrocytic endfeet. These endfeet are 
astrocytic processes that cover brain capillaries almost completely and contain 
increased number of water and potassium channels. They are attached to the 
basement membrane by dystroglycan structures.170 Astrocytic endfeet are believed to 
mediate communication between neurons and the endothelial cell and pericytes, 
however little is known about the underlying mechanisms.175  
2.2. Functions of pericytes 
2.2.1. Communication between endothelial cells and pericytes 
Endothelial cells and pericytes are interdependent and communicate closely. The only 
separation between them is a thin basement membrane, which allows direct contact of 
both cell types.171  Pericytes and endothelial cells communicate via different growth 
factors like transforming growth factor β (TGF β), platelet derived growth factor b 
(PDGF b), sphingosin-1 phosphate, angiopoietins and notch three.176, 177 These factors 
are especially important for the maturation of vessels during angiogenesis165 and for the 
maintenance of the BBB.178  
TGF β signaling between pericytes and endothelial cells is important for a functional 
vascular development. TGF β secreted by pericytes induces endothelium maturation 
and BBB formation. TGF β secreted by endothelial cells in turn induces extracellular 
matrix production and contractile protein expression in pericytes.179  
PDGF b is essentially needed for the proliferation, migration and maturation of pericytes 
and endothelial cells. PDGF b knockout animals lack pericytes and develop cylindrical 
capillary dilations and microaneurysms that rupture during gestation.180 Soluble PDGF b 
binds to the PDGF Rβ that is expressed on pericytes and VSMC and induces their 
proliferation and migration towards the vessel.181 PDGF Rβ knockouts are prenatally 
lethal due to vascular dysfunction composed of a complete lack of pericytes combined 
with endothelial hyperplasia.182 Heterozygous animals show an age dependent 
progressive loss of pericytes that induces cerebral hypoperfusion and hypoxia.173 For 
maturation and attachment of pericytes to the endothelium a steep gradient of PDGF b 
is needed183 which is created by a positively charged C terminal sequence. The positive 
charge interacts with the negatively charged extracellular matrix and leads to retention 
of PDGF b.181 The retention motive has been a target for the creation of genetically 
modified animals because the full PDGF b knockout is embryonically lethal.180 In PDGF 
b retention motif knockouts (PDGF b ret/ret) primarily the maturation and convergence of 
pericytes to the endothelium is disturbed. Mice survive but exhibit less functional 
pericytes and a phenotype, which is associated to a disturbed BBB.183 PDGF b ret/ret 
knockout mice are important for investigations on the role of pericytes in health and 
disease. 
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2.2.2. Contractility 
Already Rouget suggested a contractile function for pericytes in his first characterization 
of the cell type. The location of pericytes along vessels that do not exhibit a smooth 
muscle cell layer as well as their vessel-wrapping morphology made this assumption 
reasonable. Later the evidence that pericytes express contractile elements like smooth 
muscle myosin and tropomyosin strengthened this hypothesis.184, 185 However the 
expression of contractile elements seems to be heterogeneous in different pericyte 
subtypes. Differential histological staining of retinal pericytes subgroups indicated that 
mid-capillary pericytes in contrast to pre- and postcapillaries do not express the 
contractile form of smooth muscle actin.162 A more recent study however claims an 
expression of αSMA even in mid-capillaries.186 Furthermore pericytes express receptors 
for vasoactive substances like catecholamines187 and vasopressin.188 Especially 
interesting in the context of SAH is that pericytes express endothelin-1 receptors.189 
Endothelin-1 induces a reorganization of contractile filaments in vitro and leads to 
contraction in cultured retinal pericytes.189 If the contraction mechanisms are alike in the 
brain, pericytes might be susceptible for increased endothelin-1 levels after SAH and 
contribute to pathological vasoconstriction.81 Interestingly dilation of pericytes might be 
mediated by NO that is secreted by the endothelium.190 Thus also in the context of 
decreased NO levels after SAH a pathomechanistic role of pericytes can be suspected.  
Direct evidence for pericytes constriction has to date primarily been shown in vitro. 
Experimental evidence for pericyte contraction and dilation upon superfusion with 
vasoactive substances exists in different cell culture studies.191 Pericytes that are 
cultured three dimensionally in a collagen gel constrict upon exposure with 
acetylcholine and noradrenaline. In turn they relax upon superfusion with papaverine, a 
potent smooth muscle cell dilator.192 Pericytes that are cultured on a deformable silicone 
substrate show a wrinkling response that is mediated by actomyosin and is great 
enough to affect underlying material.193 Evidence for pericyte contraction in vivo 
however is sparse. A study on cochlear pericytes shows that they constrict in response 
to increased extracellular Ca2+ and K+ but not noradrenaline.194 The functional evidence 
of pericyte constriction in vivo is technically demanding and therefore remains a 
phenomenon that needs further investigations. 
2.2.2.1. Neurovascular coupling 
It is still under debate whether pericytes are involved in NVC response although they 
have long been suspected to be involved in the adaptation of CBF to neuronal activity. 
Today increasing evidence supports that pericytes actively regulate capillary diameter. 
The metabolic state of surrounding neuronal tissue affects pericyte tone.195 Pericytes 
constrict and narrow the vessel lumen in response to superfusion with ATP and 
noradrenaline which is reversible by superfusion with glutamate.196 These experimental 
data are supported by the finding that pericyte-deficient mice show an attenuated CBF 
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response to neuronal activity.173 An in vivo study shows that capillaries dilate similar to 
penetrating arterioles in response to increased neuronal activity by forepaw 
stimulation.197 Recently a study on the time course of vasodilation of different vessel 
categories during whisker stimulation was published.198 They found that capillaries 
dilate first, even before penetrating arterioles, and that the sites of vasodilation co-
localized with pericytes location.198 However a conflicting in vivo study suggests that 
pericytes were able to regulate the vessel diameter but that they were not mediating the 
physiological NVC response. Superfusion with a thromboxane A2 analogue constricted 
pericytes but seizure like neuronal activity did not dilate them. The authors conclude 
that pericytes can regulate the vessel diameter but are primarily involved under 
pathological condition and rather do not mediate physiological hyperemia.199 These 
conflicting results show that the role of pericytes in NVC response is difficult to tackle 
and that further studies are needed to find conclusive answers. 
2.2.2.2. Ca2+ signaling in pericytes  
As pericytes express contractile elements and have the ability to constrict the question 
arises how tonicity of pericytes is mediated. In VSMC signaling cascades that induce 
cell constriction and dilation are well characterized:200 An elevated intracellular Ca2+ 
concentration leads to an activation of myosin light chain kinase which induces 
phosphorylation of the myosin light chain and initiates its contraction. A relaxation of 
VSMC in turn is mediated by low intracellular Ca2+ levels and a low activity of myosin 
light chain kinase. Superfusion of cultured pericytes with acetylcholine induces a 
sustained increase in Ca2+.192 Another study identified triggers of increased cytosolic 
Ca2+ in pericytes: The Ca2+ ionophore A23187 as well as high concentration of K+, 
tetraethylammonium and charbybdothoin significantly increased Ca2+ concentration in 
pericytes. Conversely the vasoactive substances angiotensin 2, acetylcholine and 
endothelin-1 cause a biphasic intracellular Ca2+ response.201 These data indicate that a 
physiological as well as a potential pathological pericyte constriction might be mediated 
by increased intracellular Ca2+ concentration. 
2.3. Pericytes in ischemia 
The role of cerebral pericytes in ischemia has only recently moved into the focus of 
research.202 Studies that are performed in vivo are sparse and reveal conflicting results. 
Therefore the role of pericytes in ischemic brain conditions needs to be further 
elucidated. To date three different pathophysiological reactions of pericytes to ischemia 
have been identified: constriction, migration/plasticity and cell death:  
After transient ischemia reperfusion of cerebral capillaries is impaired even if the big 
brain supplying arteries are reopening. This phenomenon is known as the no-reflow 
phenomenon.128 Recently experimental evidence on the contribution of pericytes to 
disturbed reperfusion of cerebral capillaries emerged. Yemisci et al. found that oxidative 
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stress induced pericyte constriction upon ischemia. It led to capillary narrowing that 
obstructed the flow of red blood cells. The suppression of the oxidative stress alleviated 
pericyte contraction and preserved the microcirculation.203 However this study was not 
performed in vivo, which makes morphological findings difficult to interpret. A recent 
study shows that pericytes constrict after onset of ischemia and subsequently die in 
rigor mortis. This rigor further strangulates vessel volume.198 This study was performed 
in cerebellar slices in the condition of oxygen-glucose deprivation, which might exhibit 
different pathophysiology than ischemic condition in vivo. Therefore in vivo studies in 
the cerebral cortex are needed to confirm pericyte constriction upon ischemia. 
These data indicate that pericytes are susceptible to ischemic conditions204 and might 
undergo early cell death upon cerebral ischemia. A study investigated pericyte survival 
24 hours after ischemia. Dying cells were labeled with IB4 and propidium iodide and 
revealed that about 70% of pericytes died early after focal cerebral ischemia.198 Another 
study confirms pericyte death on day one to three after ischemia.205 
Interestingly pericytes migrate away from the vessel during postischemic hypoperfusion 
within 24 hours after ischemia.206 In an ultrastructural study of pericytes in hypoxic 
condition pericytes show characteristic cell protrusions that are directed towards the 
parenchyma. After two hours of hypoxia every third pericyte starts to migrate from its 
original location, leaving a thickened basal lamina.207 A more recent ultrastructural study 
shows that hypothermia delays pericyte migratory behavior after transient cerebral 
ischemia.208 Pericyte migration might disrupt the BBB thereby increasing vascular 
permeability.209 The triggers and purpose of pericyte migration are still unknown.  
Proliferation of pericytes in the ischemic core has been suggested after experimental 
stroke. An upregulation of the vascular expression of PDGF Rβ was found 48 hours 
after transient middle cerebral artery occlusion.210 Another study investigating plasticity 
of pericytes after ischemia finds that pericytes proliferate and migrate upon distal 
permanent ischemia. At seven days after stroke the number of pericytes is ten-fold in 
the peri-ischemic area compared to the contralateral side. These activated parenchymal 
pericytes express microglial marker and show a transcription pattern similar to 
microglial cells.211 Therefore they might take over immune function.212 Another recent 
study claims that perivascular stromal cells change their phenotype and are involved in 
scar formation after cerebral ischemia. These cells are PDGF Rβ+ and CD105+ and 
originate from the NVU.205 
  
 
 
23 
 
 
In summary the literature on the role of pericytes in ischemia is heterogeneous and 
pericyte pathophysiology therefore needs to be further investigated in more detail. In 
vivo studies will help to elucidate the dynamics and fate of pericytes in ischemia.  
The role of pericytes after SAH has not been investigated to date. As SAH and ischemic 
stroke share common pathophysiologies e.g. tissue hypoxia it is likely that pericytes 
react to SAH in a similar way as observed in focal cerebral ischemia.  Therefore one 
aim of the current thesis was to characterize the reaction of pericytes to SAH in vivo. 
Pericyte survival as well as a possible migratory behavior were addressed. However 
most interesting for the early pathophysiology after SAH is the involvement of pericytes 
in the formation of vessel spasm. If capillaries constrict after SAH, pericytes are the 
associated contractile cell type that can mediate vessel constrictions.   
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A murine model of subarachnoid hemorrhage
Aim of the study: 
The endovascular filament perforation model is the animal model which resembles the 
pathophysiological situation in SAH patients most closely.213 It has been invented by 
Bederson et al. and Veelken et al.62, 63 and primarily used and optimized in rats, a 
laboratory animal frequently used in medical science. Since studies on transgenic 
animals were moving into the focus of biomedical research, mice were replacing rats as 
experimental animals. Subsequently researchers had to adopt animal models from rats 
to mice. Especially the SAH model was not easily applicable in mice because of the 
small body size and blood volume. The size of the filament that perforates the vessel as 
well as adequate physiological monitoring are crucial for successful SAH induction.61 
Although the endovascular filament perforation model was described in mice65, 66 it was 
rarely used in SAH research. Instead alternative SAH models like the blood injection 
model were employed because they are quick and easy to perform. However 
investigations on the pathophysiology of a disease should always be performed in the 
animal model that resembles the situation in patients best. Therefore we decided to 
further standardize the model and publish a methodological video publication. 
Guidelines for the monitoring of physiologic conditions during SAH induction and 
exemplary data are provided.  
 
Moreover the distribution of extravasated blood inside the subarachnoid space after 
filament perforation is described. Blood distribution after SAH has never been 
investigated in mice but might be relevant for the pathophysiology because free 
hemoglobin is suspected to be involved in the formation of early brain injury.133 
Furthermore the blood distribution pattern in the perivascular space might have 
implications on pial vessel pathology and microthrombosis. 
 
Subarachnoid blood distributes in the subarachnoid space primarily along superficial 
arterioles i.e. branches of the middle cerebral artery. Moreover perivascular blood 
stretches on the brain surface as far as to the dorsal cortices. This finding is relevant for 
subsequent studies where the cortical microcirculation after SAH is investigated in vivo. 
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Short Abstract 
A standardized mouse model of subarachnoid 
hemorrhage by intraluminal Circle of Willis 
perforation is described. Vessel perforation and 
subarachnoid bleeding are monitored by 
intracranial pressure monitoring. In addition 
various vital parameters are recorded and 
controlled to maintain physiologic conditions. 
Long Abstract 
In this video publication a standardized mouse 
model of subarachnoid hemorrhage (SAH) is 
presented. Bleeding is induced by endovascular 
Circle of Willis perforation (CWp) and proven by 
intracranial pressure (ICP) monitoring. Thereby a 
homogenous blood distribution in subarachnoid 
spaces surrounding the arterial circulation and 
cerebellar fissures is achieved. Animal physiology 
is maintained by intubation, mechanical 
ventilation, and continuous on-line monitoring of 
various physiological and cardiovascular 
parameters: body temperature, systemic blood 
pressure, heart rate, and hemoglobin saturation. 
Thereby the cerebral perfusion pressure can be 
tightly monitored resulting in a less variable 
volume of extravasated blood. This allows a 
better standardization of endovascular filament 
perforation in mice and makes the whole model 
highly reproducible. Thus it is readily available for 
pharmacological and pathophysiological studies 
in wildtype and genetically altered mice. 
Introduction 
SAH is the stroke subtype with the least 
beneficial outcome for patients: 40% of the 
patients die within a month after the bleeding1 
and survivors rarely have a clinically favorable 
outcome.  
The large majority of spontaneous SAHs (80%) 
are caused by rupture of intracranial aneurysms 
which are mostly located along the anterior and 
posterior communicating artery, the basilar artery, 
and middle cerebral artery (MCA)2. 
Such aneurysms are difficult to model in animals 
and therefore animal models of SAH are either 
performed by injection of blood into the 
subarachnoid space/cerebral ventricles or by 
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endovascular perforation of a subarachnoid 
vessel.  
Autologous blood injection into the cisterna 
magna is easy to perform and reproducible as the 
blood volume can be directly controlled3. 
Unfortunately some aspects of the SAH 
pathophysiology, e.g. the vessel injury, cannot be 
modeled by this procedure. Another technical 
approach for induction of SAH is the opening of 
an intracisternal vein4. 
However, the intraluminal CWp at the MCA 
branch appears to be the procedure that models 
the pathophysiology in humans most closely5. 
The method was developed and first described in 
rats by Bederson and colleagues and at the same 
time by Veelken and colleagues6, 7. Later the 
intraluminal perforation model was adapted to 
mice8, 9. A filament is inserted into the external 
carotid artery (ECA) and advanced to the skull 
base via the internal carotid artery (ICA). At the 
branching point of the MCA the filament 
perforates the vessel and induces a bleeding into 
the subarachnoid space at the skull base. The 
blood then distributes into the remaining 
subarachnoid space along fissures and blood 
vessels. Bleeding is stopped by clot formation at 
the site of perforation but re-bleedings, which are 
often detrimental in patients10, can occur. 
Accordingly, the endovascular filament model 
became a widely used SAH model during the 
past few years. The most frequently mentioned 
drawback of the filament perforation model is that 
bleeding volume cannot be directly controlled and 
may therefore be variable. This variability can 
significantly be reduced by tight control of animal 
physiology and post-hemorrhagic ICP. 
Mice have the great advantage that a large 
number of genetically modified strains are 
available. However, due to their small size 
surgical procedures tend to be more complex 
than in larger species, e.g. rats or rabbits. 
Therefore the downscaling of techniques 
developed for rats to mice often does not lead to 
the desired results, e.g. as mice have a very 
limited body weight and blood volume non-
invasive techniques for blood pressure and blood 
gas analysis as well as for hemoglobin saturation 
and heart rate monitoring have to be applied 
whenever possible. 
Accordingly, the aim of the current publication is 
to describe the filament perforation model for 
SAH in mice and to demonstrate how this model 
can be performed in a standardized and highly 
reproducible manner.   
Protocol Text 
All surgical procedures were subjected to ethical 
review and approved by the government of Upper 
Bavaria (reference number: 55.2-1-54-2532.3-13-
13 and -2532-136-11). Animals are male 
C57BL/6 mice with a body weight of 
approximately 25 g. 
 1.  Animal preparation 
 
1.1) Induce anesthesia by putting the mouse 
into a chamber. Flush the chamber with 5% 
isoflurane until the animal loses consciousness. 
 
1.2) Inject premixed anesthetics 
intraperitoneally: fentanyl (0.05 mg/kg), 
midazolam (5 mg/kg) and medetomidine (0.5 
mg/kg).Check reflexes before and regularly 
during the procedure. Reinject one third of the 
initial amount hourly to maintain anesthesia. 
 
1.3) Intubate oro-tracheally with a tube made 
from a 20G venous catheter11. For intubation fix 
the animal on a slanted platform (30°), retract the 
tongue with bent forceps, visualize the vocal 
cords under an operation microscope and insert 
the tube into the trachea during inspiration. 
 
1.4) Place the mouse in a prone position and 
check the correct placement of the tube with a 
piece of cotton or a microcapnograph. 
 
1.5) Connect the intubation tube to the 
respirator. Ventilate the mouse with room air 
supplemented with 25% oxygen with a frequency 
of 180- 220 breaths/min and a stroke volume of 
200- 250 µl. 
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1.6) Connect the intubation tube to the 
microcapnograph. Maintain the endexpiratory 
pCO2 at 30 mmHg by adjusting the ventilation 
frequency. 
 
1.7) Insert a rectal temperature probe and 
place the animal on a heating pad in order to 
maintain 37°C core body temperature. 
 
1.8) Apply the annular pulsoximeter sensor on 
the right hind paw. 
 
1.9) Open the skin above the skull with a pair 
of scissors. The incision should be approximately 
0.5 cm long and between ear and eye. 
 
1.10) Dissect the left temporal muscle with a 
scalpel from the temporal bone. 
 
1.11) Glue the laser Doppler flowmeter (LDF) 
probe onthe left temporal bone. Hold the probe in 
a fixed position until the glue hardens. 
 
1.12) Drill a hole of approximately 1.5 mm 
diameter with a dental drill into the left temporal 
bone. Cool the bone with saline to prevent heat 
damage. 
 
1.13) Insert the ICP probe into the cranial 
cavity. Push forward as dorsally as possible to 
prevent brain tissue damage and bleeding. 
 
1.14) If the probe is at the right position, fix and 
seal it with cement. Let the cement dry for 5 min. 
 
1.15) Turn the mouse carefully to a supine 
position. 
 
1.16) For continuous blood pressure monitoring 
catheterize the left femoral artery. 
 
1.17) Connect the femoral catheter to the blood 
pressure monitoring device. 
 
2. SAH induction 
 
2.1) Open the skin with a pair of scissors from 
sternum to chin. Dissect the connective tissue 
bluntly and push the salivary glands aside.  
 
2.2) Expose the left common carotid artery 
(CCA) and mobilize it. Preserve the vagal nerve 
which runs in the same connective tissue sheath 
as the CCA. Move cranial and expose and 
mobilize the ICA and the ECA using the same 
technique. 
 
2.3) Ligate the ECA as far cranially as 
possible. 
 
2.4) Prearrange two more ligations for the 
filament around the ECA. 
 
2.5) Occlude the CCA and the ICA temporarily 
with microclips. Position the microclips with a 
microclip applicator. Make sure the clips are 
applied correctly by gently pulling them back. 
 
2.6) Cut a hole for the filament insertion into 
the ECA with a vessel scissors. 
 
2.7) Insert a Prolene 5-0 filament with 12mm 
length into the ECA. 
 
2.8) Close the insertion site with one 
prearranged ligation. 
 
2.9) Remove the microclips with a microclip 
applicator from the CCA and the ICA. 
 
2.10) Advance the filament with a forceps into 
the ICA until the ICP rises. A sudden rise of the 
ICP indicates bleeding induction. 
 
2.11) Withdraw the filament immediately and 
ligate the ECA by closing both prearranged 
ligations consecutively. This prevents bleeding 
out of the insertion site. 
 
2.12) Suture the skin wound. 
 
2.13) Monitor the physiologic parameters of the 
animal for another 20 min. 
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2.14) Remove ICP and LDF probes and suture 
the skin wound. 
 
3. End of experiment 
 
3.1) Perfuse the animal transcardially with 20 
ml of saline (room temperature) followed by 20 ml 
of 4 % PFA in PBS (4°C). 
 
3.2) Dissect the brain out of the skull. Cut the 
skull in the midline and between the orbital 
cavities. Then peel the bone from the brain. 
 
3.3) Evaluate the blood distribution in the 
subarachnoid space. 
 
Figure 1: Representative ICP values of 5 animals after SAH. 
Figure 2: Representative blood pressure values of 5 animals after 
SAH. 
 
Figure 3: Representative laser Doppler flowmeter values of 5 animals 
after SAH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Blood distribution along brain supplying arteries. 
Representative blood distribution of 5 animals after SAH. Red lines 
indicate blood distribution along brain supplying arteries. 
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Figure 5: Survival curve after SAH. Survival curve following SAH in 49 
male C57BL/6 mice. 
Results 
Mortality 
Once the surgery technique is mastered the 
procedure does not elicit any intraoperative 
mortality. Also bleeding can be achieved in 
virtually all animals. Postoperative mortality is 30- 
40 % with most animals dying on day 1 after 
surgery (Fig.5). 
ICP values after SAH 
The ICP before bleeding is around 4 mmHg. 
Bleeding results in a sharp increase of the ICP up 
to 120 mmHg. ICP values then stabilize within 5 
min at approximately 30 mmHg (Fig.1). At 24 hrs 
after bleeding the ICP is still slightly elevated to 
10 mmHg5. 
Blood pressure after SAH 
Blood pressure rises immediately after bleeding 
induction (Fig.2). This is due to the Cushing reflex 
which is initiated by elevated ICP. 
Cerebral perfusion after SAH 
After bleeding induction a dramatic decrease of 
cerebral perfusion can be monitored. Reperfusion 
to an individually different level occurs within 5 
min after the insult (Fig.3).  
Blood distributes along brain supplying 
arteries and cerebellar fissures 
We perfused animals 3 hrs after SAH 
transcardially with 20 ml of saline followed by 20 
ml of chilled 4 % PFA. The brain was carefully 
removed and blood distribution in the 
subarachnoid space was observed. Blood 
distributes along the perivascular space of brain 
supplying arteries towards the dorsal cortex. In all 
cases the extravasated blood covered the MCA 
up to the second branching. The side ipsilateral to 
the hemorrhage was covered with more blood 
than the contralateral hemisphere (Fig.4).  
Blood distribution does not correlate with ICP 
rise 
In 5 animals we investigated whether the rise of 
the ICP during SAH has an impact on blood 
distribution in the subarachnoid space. One 
hypothesis was that animals which show only a 
moderate ICP rise during SAH might exhibit less 
extravasated blood which then does not distribute 
to the dorsal parts of the cortex. We found that 
only the size of the hematoma at the skull base 
seems to correlate with the ICP rise. Blood 
distribution along the brain supplying arteries did 
not differ between animals with different ICP peak 
values. 
Discussion 
Treatment options after SAH are scarce and 
mostly inefficacious. Therefore the 
pathophysiology of post-hemorrhagic brain 
damage needs to be further understood in order 
to identify new therapeutic targets and develop 
novel therapeutic approaches. Standardized and 
well reproducible animal models in genetically 
modified animals, i.e. mice, are crucial for such 
investigations. The CWp model has become a 
widely used model for SAH as it resembles the 
pathophysiology in humans closely; however, its 
use in mice is hampered by low reproducibility 
and a high interpersonal variability. Variations of 
the model are caused by different anesthetic 
protocols which alter physiologic conditions. The 
amount of bleeding varies between animals due 
to vessel reactivity, blood pressure and 
coagulation differences12. Thus it is important to 
monitor physiologic conditions throughout the 
procedure and to establish surgical and 
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monitoring protocols which reduce the variability 
of this model. 
Blood distribution after SAH may be different 
between species. In the rat model blood seems to 
be equally distributed across both cerebral 
hemispheres6. As human brains show a 
gyrencephalic architecture the blood is likely to 
distribute mainly along brain sulci and not 
primarily along vessels. On the other hand brain 
supplying arteries run in those sulci e.g. the MCA 
in the lateral sulcus. Thus vessel pathologies 
might be similar in rodent animal models and the 
human brain. 
In our laboratory we use a combination of 
fentanyl, medetomidine and midazolam as 
described above for surgical anesthesia. This 
combination has a relatively small effect on blood 
pressure and vessel reactivity11. In contrast, 
isoflurane, a widely used anesthetic in SAH 
research, leads to peripheral vasodilation, 
severely impaired cerebral autoregulation13, and 
low blood pressure immediately after SAH12, 13, 
findings which are not regularly associated with 
the early pathophysiology of SAH in humans. 
Hence, the use of an anesthetic protocol which 
does not disturb post-hemorrhagic 
pathophysiology is an important prerequisite for a 
valid experimental SAH model. 
The amount of bleeding depends on the vessel 
lesion and varies therefore with filament size14. 
Another crucial step of the model is the 
withdrawal of the filament after vessel perforation. 
Blood flow in the ICA is disrupted by the filament 
and a delayed withdrawal may result in smaller 
bleedings. Accordingly, it is crucial to standardize 
the time between vessel perforation and filament 
withdrawal. This is of course only possible if the 
time point of vessel perforation can be 
determined with high temporal precision. In our 
set-up this is achieved by continuous 
measurement of ICP. A sharp increase in ICP 
indicates successful vessel perforation and allows 
thereby the standardization of filament withdrawal 
and hence bleeding intensity. In addition, ICP-
controlled vessel perforation prevents that the 
filament is advanced too far thereby preventing 
brain tissue damage. Accordingly, continuous ICP 
measurement is an excellent technique to 
minimize the variability of the murine SAH model. 
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Impairment of the parenchymal cerebral microcirculation after 
subarachnoid hemorrhage
Aim of the study: 
Cerebral ischemia, which correlates with the clinical score of patients, occurs early after 
SAH.100 The underlying pathomechanism is not clear to date but two different concepts 
for the formation of cerebral ischemia after SAH are discussed: One hypothesis is that 
parenchymal vessels are obstructed due to leukocyte-endothelium interactions or 
formation of microthrombi that plug the vessel lumen. The so called no-reflow 
phenomenon, which is observed after focal ischemia hampers reperfusion of 
capillaries.127 A second hypothesis is that vessels constrict acutely in response to 
SAH.99 In patients as well as in a mouse model of SAH pearl-string like 
microvasospasm of superficial brain supplying arteries evolve early after the 
bleeding.147-150  
 
We address the question whether vessel spasm on the surface of the brain have a 
negative impact on blood flow dynamics of capillaries in the brain parenchyma. The 
parenchyma is the localization where blood gases and nutrients cross the blood brain 
barrier to provide neurons and glia cells with energy and metabolites. It is also the 
location where actual brain damage after SAH occurs.214 Therefore it is important to 
know whether vascular dysfunction on the brain surface also manifests deep in the 
cortex. To address this question we made use of two-photon microscopy after SAH. 
Vessel diameter was reduced by 23% in superficial vessels and three different types of 
superficial vessel constrictions were identified. In addition to pearl-string like 
constrictions global vessel constrictions over long vessel segments as well as 
bottleneck constrictions, which are more pronounced in distal vessel areas were 
identified. The reduction of vessel diameter was accompanied by reduced blood flow 
velocity in superficial vessels. Taken together the data shows that less blood volume 
passes superficial arteries and eventually reaches the cerebral microcirculation. It 
manifests in a reduction of perfused vessel volume of parenchymal capillaries after 
SAH. In order to test the occurrence of the no-reflow phenomenon after SAH we further 
investigated whether perfusion deficits are caused by plugging of vessels with 
leukocytes. SAH induced a five-fold increase in leukocyte-endothelium interactions but 
absolute numbers were too low to explain the severe reduction of perfused 
microvessels.  
 
This study shows that the cortical microcirculation is affected early after SAH and that 
superficial microvasospasm are the suggested pathomechanism. However it needs to 
be further addressed whether the reduction of vessel diameter and blood flow velocity 
on the brain surface alone trigger parenchymal perfusion deficits or whether also 
capillaries constrict after SAH. 
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Abstract 
The outcome after subarachnoid hemorrhage 
(SAH) depends on the occurrence of early 
cerebral ischemia. Spasms of arteries in the 
subarachnoid space are a suggested mechanism. 
However, if these spasms also influence 
microperfusion in the brain parenchyma, where 
the actual damage occurs, remains unclear. The 
aim of the current study is therefore to investigate 
the parenchymal microcirculation after SAH using 
two-photon in vivo microscopy.  
Vessel diameter and blood flow velocity in pial 
and parenchymal microvessels as well as 
perfused vessel volume were measured by two-
photon microscopy three hours after SAH. 
Leukocyte plugging and microthrombi formation 
was investigated in a separate group of 
experiments using Rhodamine 6G as a leukocyte 
marker. 
 
Arteriolar diameter and blood flow velocity in the 
pial microcirculation decreased by 23% and 54%, 
respectively. At the same time the volume of 
perfused microvessels in the cerebral 
parenchyma dropped by 68% indicating severe 
parenchymal perfusion deficits. The number of 
leukocytes plugging in parenchymal microvessels 
increased five-fold. 
The current study demonstrates that SAH-
induced microvasospasm of pial arterioles are 
associated with a severe reduction of 
parenchymal perfusion. Hence, alterations of the 
pial and parenchymal microcirculation may 
together be responsible for the ischemic brain 
damage observed after SAH. The cerebral 
microcirculation represents therefore a promising 
target for the development of novel therapeutic 
strategies to prevent brain injury after SAH. 
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Introduction 
Subarachnoid hemorrhage (SAH) describes a 
bleeding into the subarachnoid space, the 
cerebrospinal fluid filled volume between the 
arachnoid membrane and the pia mater which 
hosts the large brain supplying arteries before 
they enter the brain parenchyma. SAH accounts 
for about 3 to 6% of all strokes, but it has a high 
socio-economic burden that almost equals that of 
ischemic stroke since it affects younger patients.1 
Over all, SAH has a mortality of 50% with 21% of 
patients dying within the first 24 hours after the 
bleeding.2 
In most cases SAH is caused by a rupture of an 
aneurysm at the base of the brain.3 Vessel 
rupture and the evolving hematoma cause high 
intracranial pressure (ICP) leading to the 
reduction of cerebral blood flow (CBF) and 
eventually to global cerebral ischemia.4 Patients 
reaching the hospital after this acute phase often 
suffer also from focal cerebral ischemia5 which 
further aggravates global ischemia-induced brain 
damage. Early ischemia has a negative impact on 
three-month outcome after SAH.6 
The mechanisms underlying early focal cerebral 
ischemia after SAH are poorly understood. They 
may include acute spasms of large cerebral 
vessels as seen in histological examinations after 
experimental SAH7 or acute spasms and 
microthrombosis of the pial microcirculation 
described in SAH patients8, 9 and experimentally 
in mice.10 The functional consequence of these 
spasms is largely unknown, i.e. whether 
constrictions of pial arterioles result in 
disturbance of circulation in the brain 
parenchyma, the area where post-hemorrhagic 
ischemia and brain damage actually occur. 
Accordingly, the aim of the current study was to 
visualize the parenchymal microcirculation in vivo 
by two-photon microscopy and to investigate the 
effect of SAH on parenchymal microvascular 
perfusion. 
 
 
Material and Methods 
C57Bl6 mice obtained from Charles River 
(Sulzfeld, Germany) were used for the current 
study. Mice were group housed in individually 
ventilated cages with access to food pellets and 
water ad libitum. Experiments are approved by 
the Government of Upper Bavaria.  
Anesthesia 
Anesthesia was induced in a chamber with 
increasing isoflurane concentrations to a 
maximum of 5% and maintained by 
intraperitoneal injection of 0.05 mg/kg fentanyl 
(Janssen- Cilac, Neuss, Germany), 0.5 mg/kg 
medetomidine (Pfizer, USA), and 5 mg/kg 
midazolam (Braun, Germany). Afterwards 
animals were placed on a feedback controlled 
heating pad for maintenance of body temperature 
at 37°C. Mice received 4 mg/kg carprofen (Pfizer, 
USA) subcutaneously for preoperative analgesia 
and were intubated and mechanically ventilated 
(Minivent 845, Hugo Sachs, Germany). A 
microcapnograph (Model 340, Hugo Sachs, 
Germany) was used to adjust the ventilation 
frequency to keep blood gases within the 
physiological range during the experiment. A 
pulsoximeter sensor (MouseSTAT, Kent 
Scientific, USA) was placed at the right hind paw 
and peripheral oxygen saturation as well as heart 
rate were continuously monitored during 
anesthesia. Surgical anesthesia was maintained 
by regular reinjection of anesthetics. 
SAH model 
SAH was is induced by endovascular perforation 
of the Circle of Willis as described previously.11 
Briefly, an intracranial pressure probe (Codman, 
Johnson & Johnson, UK) was implanted into the 
epidural space and a laser Doppler probe 
(Periflux 5000, Perimed, Sweden) was fixed on 
the temporal bone. The mouse was placed in a 
supine position and the left carotid arteries were 
exposed. A prolene filament (5-0) was inserted 
into the external carotid artery and advanced 
through the internal carotid artery towards the 
Circle of Willis until ICP rose sharply indicating 
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SAH induction. The filament was withdrawn 
immediately and the external carotid artery was 
sutured. Animals were monitored for 20 minutes, 
wounds were sutured and surgery was 
terminated by a subcutaneous injection of 1.2 
mg/kg naloxone (Actavis, Ireland, USA), 0.5 
mg/kg flumazenil (Inresa, Germany) and 2.5 
mg/kg atipamezole (Pfizer, USA). In sham 
operated animals the filament was advanced up 
to the Circle of Willis without vessel perforation.  
Two-photon microscopy 
After topic application of lidocaine (2% HCl) the 
bone of the parietal cortex was thinned12 or a 
glass window (four x four mm) was prepared as 
previously described.13 Mice were fixed in a nose 
clamp (David Kopf instruments, USA) and placed 
under a Zeiss LSM 7 microscope equipped with a 
Li:Ti laser (Chameleon, Coherent, USA) and a 
20x water immersion objective (Plan Apochromat, 
NA 1.0, Zeiss, Germany). 
Fluoreszeinisothiocyanate (FITC) dextran (0.5% 
in saline Sigma Aldrich, USA) or 
tetramethylrhodamine (TMRM) (0.5% in saline, 
Sigma Aldrich, USA) was injected via the tail vein 
or into the femoral catheter to stain the blood 
plasma. Rhodamine 6G (0.5% in saline, Sigma 
Aldrich, USA) was used to stain nucleated blood 
cells. Excitation wavelength was 800 nm for FITC 
and TMRM and 840 nm for FITC and Rhodamine 
6G respectively. Fluorescence emission was 
detected using GaAsP-NDD detectors and 500-
550 nm band pass filters for green fluorescence 
and 565-610 nm band pass filters for red 
fluorescence. Z-stacks (one µm step distance) of 
four randomly chosen regions of interest (ROI) 
with a size of 609 x 609 µm were obtained with 
0.7x zoom up to a targeted minimum depth of 150 
µm or 400 µm. For the measurement of blood 
flow velocity line scans were performed along 
randomly chosen pial arteries with a diameter of 
12-60 µm. Each vessel was scanned 1000 times 
with maximum speed over a length of 50-100 µm. 
At the end of each experiment brains were kept 
for histological analysis. 
 
 
 
Figure 1  
Sketch of a cranial window on the left parietal cortex. Four randomly 
chosen ROI within the cranial window were investigated by two-photon 
microscopy. 
Experimental groups 
Two experimental groups were investigated: In 
group one two-photon imaging was performed 
before and three hours after SAH. In group two 
plugging of pial and parenchymal microvessels by 
leukocytes was investigated three hours after 
SAH.  
Quantification of data obtained by two-photon 
imaging 
Vessel diameter was assessed by measuring the 
maximal vessel diameter in a given Z-stack. 
Maximal vessel diameter was measured at five 
positions along randomly selected vessel 
segments of 60-80 µm lengths. At least three 
vessel segments were measured in each ROI, 
which resulted in 12 vessel segments per 
experiment. In total 89 vessel segments were 
measured in sham condition and 109 vessel 
segments in SAH condition. 
In order to obtain a value for the amount of 
perfused microvessels in a given volume of brain 
tissue, a crop (150 x 150 µm) of one ROI was 
subjected to 3D reconstruction (Imaris, Bitplane 
AG, Switzerland) and the absolute volume of all 
pixels stained with TMRM or FITC dextran was 
calculated. Perfusion deficits induced by SAH 
were quantified by comparing the total number of 
reconstructed dye-containing pixels. Superficial 
vessels including penetrating arterioles and the 
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parenchymal microcirculation were analyzed 
separately. 
Blood flow velocity was calculated by dividing the 
travelled distance (µm) by the respective travel 
time (msec) and expressed as % of baseline 
values.  
Sticking/plugging leukocytes were defined as red 
signals larger than 5 µm size which were 
immobile within 10 min. Leukocytes were 
quantified separately in pial venules and in 
parenchymal capillaries. 
Statistical analysis 
Statistical tests were performed with the 
SigmaPlot 12.0 software package (Systat 
Software Inc., USA). Groups were compared with 
the Mann Whitney U test. Differences of p < 0.05 
were considered as statistically significant. Data 
are shown in mean ± standard deviation (SD) 
unless indicated otherwise. 
Table 1 Physiological monitoring during in vivo microscopy 
Results 
During imaging systemic blood pressure, core 
body temperature, heart rate, and systemic 
hemoglobin oxygen saturation were within the 
physiological range and did not differ between 
mice subjected to SAH or sham surgery (Table 
1). In order to control and maintain a physiologic 
arterial pCO2, one of the main parameters 
determining cerebral vessels diameter, 
endexpiratory CO2 was continuously measured 
by microcapnometry and kept constant by 
adjusting the ventilation frequency. This resulted 
in physiological arterial pCO2 values. 
 
 
 
 
 
 
 
Figure 2  
A ICP measurement in mmHg during SAH/sham induction. SAH 
induction leads to a sharp increase of the ICP and stabilizes within five 
minutes at values around 14 mmHg. In sham condition ICP stays at 
baseline levels of four mmHg throughout the procedure. B rCBF values 
are shown in % of baseline. SAH induction leads to a drop in regional 
perfusion which does not recover even when ICP values stabilize. 
Physiological monitoring 
SAH induced a sharp increase of ICP to values 
above 60 mmHg. After cessation of hemorrhage 
ICP dropped to mean values of 14 mmHg (Fig. 
2A). Due to the reduction of cerebral perfusion 
pressure (CPP) the initial ICP peak was 
accompanied by a drop of regional cerebral blood 
flow (rCBF) in the hemisphere ipsilateral to the 
hemorrhage down to ischemic levels (Fig. 2B). 
Hence, animals suffer global cerebral ischemia 
for a few minutes. Despite recovery of ICP and 
the subsequent normalization of CPP rCBF 
ba
se
lin
e
SA
H 
ind
uc
tio
n
5 m
in
10
 m
in
15
 m
in
20
 m
in
IC
P
 (
m
m
H
g
)
0
20
40
60
80
100
sham
SAH
n = 6
mean +/- SD
ba
se
lin
e
SA
H 
ind
uc
tio
n
5 m
in
10
 m
in
15
 m
in
20
 m
in
15
0 m
in
rC
B
F
 (
%
 o
f 
b
a
s
e
li
n
e
)
0
20
40
60
80
100
120
140
160
sham
SAH
n = 5 - 6
mean +/- SD
  sham  SAH 
et pCO2 (mmHg) 25.6 ± 1.6 26.5 ± 1.5 
blood pressure (mmHg) 86 ± 11 84 ± 16 
temperature (°C) 37.5 ± 0.1 37.4 ± 0.2 
heart rate (beats/min) 274 ± 63 306 ± 51 
oxygen saturation (%) 97.5 ± 1.6 96.8 ± 1.5 
A 
B 
Impairment of the parenchymal cerebral microcirculation after subarachnoid hemorrhage 
 
37 
 
remained reduced after SAH. This suggests that 
mechanisms independent of CPP, i.e. spasms of 
the cerebral microcirculation, are responsible for 
post-hemorrhagic oligemia or ischemia.  
Microvasospasms of the pial arterioles after 
SAH 
The mean diameter of pial arterioles is 
significantly reduced by 23% after SAH (Fig. 3). 
71% of measured vessel segments were spastic. 
When looking at the vessel morphology after SAH 
in detail three different vessel constriction types 
were distinguishable (Fig. 4A). 68% of observed 
vessel segments revealed pearl-string like 
constrictions as shown previously by pial vessel 
imaging after SAH.10 However we detected two 
other constriction patterns. 21% of vessels 
showed an overall reduced vessel diameter over 
a long distance without additional focal 
constrictions (Fig. 4A and B, global constriction). 
A third type of spasms was characterized by an 
unchanged vessel diameter in proximal areas and 
an almost obliterated vascular lumen in more 
distal segments (Fig. 4A and B, bottleneck 
constriction). In order to further characterize the 
vessel constriction types we calculated a vessel 
constriction index, which describes the 
normalized range of vessel diameter within one 
vessel segment (see legend for details). The 
vessel constriction index is doubled after SAH 
(Fig. 4C). 
 
Figure 3 
Measurement of vessel diameter after SAH/sham. Vessel diameter 
after SAH is significantly (p < 0.01) reduced compared to sham 
condition. 
 
 
 
 
Figure 4  
A SAH induced different vessel constriction types: pearl-string 
constriction, global constriction and bottleneck constriction types were 
found in superficial arteries. Pearl-string constrictions were classified 
as vessel segments that had a 20% mean reduction of vessel diameter 
and a 30% diameter variability within the segment. The global 
constriction type was classified as a vessel segment that showed a 
reduction of vessel diameter of 20% and a variability within the 
segment of less than 30%. The bottleneck constriction type was 
characterized by more than 20% reduction and 30% variability of 
vessel diameter in conjunction with a decreased vessel diameter in 
distal segments. B After SAH 71% of the vessels were spastic with a 
mean diameter reduction of 20%. Of spastic vessels 68% showed a 
pearl-string constriction, 11% a bottleneck constriction and 21% a 
global constriction. C The vessel constriction index describes the range 
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of vessel diameters measured within one segment normalized to the 
baseline condition. The vessel constriction index was significantly (p < 
0.01) increased after SAH. 
Reduction of blood flow velocity after SAH 
Vasoconstriction could in theory be compensated 
by an increased blood flow velocity in order to 
maintain tissue perfusion. Therefore we 
measured blood flow velocity in pial arterioles 
after SAH. Instead of a compensatory increase in 
blood flow velocity we detected a reduction of 
blood flow velocity (Fig. 5B). Blood flow velocity in 
arterioles was reduced by 54% after SAH (Fig. 
5B). When plotting the reduction of blood flow 
velocity against the degree of constriction only a 
weak correlation is found (Fig. 5C), suggesting 
that constriction of vessels is not exclusively 
responsible for the reduction of pial blood flow 
velocity after SAH. Other mechanisms like 
microthrombosis or plugging of capillaries by 
leukocytes may be involved.  
 
 
 
 
 
Figure 5 
A Example of repetitive line scans for blood flow velocity measurement. 
B Blood flow velocity is shown in % of baseline in corresponding vessel 
segments. Blood flow velocity is significantly (p < 0.01) reduced after 
SAH compared to the sham situation. C Correlation of reduction of 
blood flow velocity (in %) and reduction of vessel diameter (in µm). 
Perfusion of parenchymal vessels after SAH 
After showing that SAH results in spasms of pial 
microvessels, which are located in the 
subarachnoid space and come into contact with 
blood, we wanted to know if these spasms result 
in impaired perfusion of downstream vessel 
branches, i.e. penetrating arterioles and the 
parenchymal microcirculation, which actually 
deliver oxygen and nutrients to brain tissue. To 
receive a value representing total perfusion in a 
given tissue volume, we stained the intravascular 
space with a fluorescent plasma marker, 
recorded the fluorescence by two-photon 
microscopy and counted fluorescent pixels in 3D 
(Fig. 6A). Since we previously observed that 
microvasospasms are more pronounced in small 
arterioles,10 we analyzed pial vessels and 
penetrating arterioles separately from the 
perfused parenchymal microvessels. This 
analysis demonstrates that only 57% of all 
superficial and penetrating arterioles are still 
perfused after SAH (Fig. 6B). In the parenchymal 
microcirculation only 32% of the pre-hemorrhagic 
microvascular volume is still perfused after SAH 
(Fig. 6C), a value well in line with reduction of 
rCBF obtained by cortical laser Doppler 
measurements.  
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Figure 6 
A Example of 3D vessel reconstruction with Imaris software after SAH. 
Large parts of the parenchymal microcirculation are not perfused after 
SAH. B Perfused arterial vessel volume is shown in % of baseline. 
Perfused arterial volume is significantly (p < 0.01) reduced after SAH 
compared to the sham situation. C Perfused capillary vessel volume is 
shown in % of baseline. Perfused capillary volume is significantly (p < 
0.01) reduced after SAH compared to the sham situation.  
Leukocyte adhesion and plugging after SAH 
Activated endothelium after SAH expresses 
adhesion molecules14 which results in rolling and 
sticking of leukocytes in post-capillary venules. If 
capillaries are constricted above a certain degree, 
leukocytes may get stuck and block perfusion, a 
process called leukocyte plugging.15 In the 
current study we investigated leukocyte adhesion 
in post-capillary venules and leukocyte plugging 
in capillaries in order to evaluate if the cerebro-
vascular endothelium gets activated and if 
leukocyte plugging may represent a possible 
mechanism for the loss of microcirculatory 
perfusion after SAH. After sham surgery little 
sticking or plugging leukocytes were detected 
(Fig. 7B, white bars). Three hours after SAH, 
when adhesion molecules start to be expressed 
on activated endothelium, multiple sticking (Fig. 
7A arrowhead) and plugging (Fig. 7A arrow) 
leukocytes were found in the cerebral 
microcirculation. As compared to sham operated 
mice the number of leukocytes sticking in post-
capillary venules and capillaries increased five-
fold after SAH (Fig. 7B, gray bars). Since most 
capillaries which were occluded by leukocytes 
were also filled with the plasma marker FITC-
dextran, the plugging must have occurred after 
injection of the plasma and leukocyte marker. 
Accordingly, we may have missed leukocytes 
already sticking in the microcirculation before this 
time window. The current data suggest that 
plugging leukocytes may contribute to the 
microvascular perfusion deficit observed after 
SAH.  
Discussion 
In the current study we examined the mechanism 
responsible for early cerebral ischemia after SAH 
and found that SAH induces arteriolar 
constrictions in pial arterioles and that these 
microvasospasms are associated with a heavily 
reduced perfusion of parenchymal microvessels. 
To explore for the mechanisms of parenchymal 
perfusion deficits we observed that the number of 
leukocytes plugging parenchymal capillaries 
increased five-fold after SAH. However, since the 
absolute number of plugged capillaries was too 
low to fully explain the severe perfusion deficits, 
we conclude that microvasospasms in pial 
arterioles are the main factor resulting in reduced 
cortical perfusion following SAH.  
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Figure 7  
A Example of projected microcirculation after SAH with sticking 
leukocytes (red) in parenchymal vessels and superficial venules. 
Arrows indicate sticking leukocytes in capillaries and arrowhead shows 
a sticking leukocyte in a venule. B Leukocyte-endothelium interactions 
are enhanced after SAH. In average 5 sticking leukocytes can be found 
in superficial venules of each ROI. 5 adherent leukocytes could be 
detected in the capillaries in a brain volume of 0.19 mm3. After SAH 
leukocyte-endothelium interactions are significantly increased (p < 0.05 
and p < 0.01 respectively) compared to the sham situation in capillaries 
and venules. 
Experimental approach 
In the current study we used the endovascular 
filament technique to induce SAH as it resembles 
the pathophysiology of SAH in patients most 
closely.16 However, when using this model a 
comprehensive physiological monitoring is crucial 
to obtain a standardized bleeding induction. 
Especially the measurement of ICP, as performed 
in the current study, is important to ensure a 
standardized bleeding.17 An important parameter 
which needs to be monitored and adjusted when 
studying the cerebral vasculature in vivo is the 
arterial pCO2, since CO2 is a strong and selective 
dilator of cerebral vessels. Therefore changes in 
pCO2 due to variations in respiration may 
influence and bias measurement of cerebral 
vessel diameter. Experiments in the current study 
were performed on intubated and ventilated mice 
under real-time measurement of endexpiratory 
pCO2 by microcapnometry in order to keep the 
arterial pCO2 in a physiological range. 
Cerebral blood flow after SAH 
So far it was known from experimental studies 
that acutely after SAH the sudden rise in ICP to 
values near the systemic blood pressure results 
in a severe drop of CPP and subsequent global 
ischemia.18 Within two to three minutes after SAH 
the ICP drops to about 20 mmHg and, hence, 
CCP returns to almost normal values. However, 
despite restoration of CPP CBF remains reduced 
after SAH.18 In the current study we demonstrate 
that the post-hemorrhagic reduction in CBF last 
for 3 hours after SAH and becomes more severe 
over time. The fact that the cerebral perfusion is 
significantly reduced at almost normal CCP 
values following SAH together with the 
observation that spasms of the large intracranial 
arteries occur mostly later than five days after 
SAH suggest that constrictions or obstructions of 
cerebral vessels on the level of pial arterioles or 
below are responsible for the observed reduction 
of cerebral blood flow after SAH.18, 19 Since these 
vessels are below the resolution of clinical CT 
and MR scanners it becomes clear why the 
contribution of this vascular compartment to the 
pathogenesis of SAH remained yet mostly 
unnoticed.   
The pial microcirculation after SAH 
The arterial cerebral microcirculation consists of 
three major compartments: pial arterioles feeding 
the pial microcirculation on the surface of the 
brain and draining into penetrating arterioles, 
penetrating arterioles which dive into the brain 
parenchyma, and parenchymal capillaries which 
deliver nutrients and oxygen to the brain 
parenchyma. In principle constriction or occlusion 
at all three levels of the cerebral microcirculation 
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could result in cerebral hypoperfusion or 
ischemia. The pial vasculature is the only 
compartment of the cerebral microcirculation 
investigated so far following SAH in vivo. In single 
patients as well as in experimental animals we 
and others demonstrated that pial arterioles show 
characteristic, pearl-string like constrictions 
following SAH.8, 10, 20 In mice these arterial 
microvasospasm last for up to three days after 
hemorrhage. In addition to microvasospasm 30% 
of these arterioles were occluded by 
microthrombosis.10 In the current study using two-
photon microscopy we confirmed our previous 
results and were able to demonstrate that in total 
71% of vessels are spastic after SAH. By using 
two-photon microscopy and line scanning we 
could also demonstrate that spasms of pial 
arterioles are hemodynamically relevant. Pial 
arterioles showed a reduction in blood flow 
velocity of 54% thereby proving that spasms of 
pial arterioles are not epiphenomena but indeed 
directly involved in the reduction of cerebral 
perfusion after SAH. So far the mechanisms 
causing post-hemorrhagic vasospasms are not 
completely clear. Recently we demonstrated that 
pial arterioles and cerebral blood flow following 
SAH in mice are not responsive to CO2,21 a 
selective cerebral vasodilator which exerts its 
activity through vascular and neuronal nitric oxide 
(NO).22, 23 Accordingly, the lack of CO2 reactivity 
after SAH suggests that perivascular blood blocks 
NO signaling thereby causing vasoconstriction. 
Further studies, however, need to clarify whether 
this conclusion can be proven experimentally and 
whether influencing NO signaling may represent 
a therapeutic option after SAH.  
The parenchymal microcirculation after SAH 
As mentioned above, the lack of high-resolution 
deep brain imaging technology did not allow 
studying the effect of SAH and pial artery spasms 
on the parenchymal microcirculation so far. 
Accordingly, it was not known if SAH has an 
effect on parenchymal microperfusion. Our 
current experiments demonstrate that the 
parenchymal microcirculation is severely affected 
after SAH. The arterial volume is reduced to 57% 
after SAH. When investigating the parenchymal 
microcirculation this fraction of no longer perfused 
vessels is even 68%. These data demonstrate 
that not only the pial but also the parenchymal 
microperfusion is severely compromised after 
SAH and that the microcirculation plays an 
important role for the pathogenesis of post-
hemorrhagic ischemia. As discussed for pial 
microvessels above, also the mechanisms for the 
lack of perfusion of parenchymal microvessels is 
largely unknown. One obvious possibility is that 
the constrictions and microthrombi observed in 
pial arterioles restrict blood flow to the brain 
parenchyma thereby causing the reduction of 
parenchymal perfusion. Complete occlusion of 
one single penetrating arteriole on the pial 
surface has already effects on the capillary 
perfusion in its territory.24 Accordingly, our data 
suggest that subarachnoid blood after SAH 
constricts pial arterioles and this may result in 
wide spread loss of parenchymal perfusion. 
Another possible mechanism for the lack of 
parenchymal perfusion may be leukocytes that 
interact with the endothelium after SAH.25 This is 
a likely event, since it is well known that 
leukocytes sticking in brain capillaries contribute 
to the “no-reflow” following focal cerebral 
ischemia.15 Accordingly, it could well be that the 
observed changes in the cerebral microcirculation 
after SAH are caused by the initial post-
hemorrhagic global ischemia and are not 
secondary to changes in the pial microcirculation. 
If this was true, we should be able to detect a 
considerable amount of leukocytes obstructing 
parenchymal capillaries in our experiments. In 
fact, we found a five-fold increase of the number 
of leukocytes sticking in parenchymal 
microvessels after SAH as compared to sham. 
When considering that extremely few leukocytes 
stick to capillaries in normal brain and when 
looking at the absolute number of sticking cells, 
i.e. five sticking leukocytes in a volume of 0.19 
mm3, it becomes obvious that despite this 
significant increase of the number of sticking 
leukocytes, the biological relevance of leukocytes 
obstructing parenchymal microvessels after SAH 
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is most likely negligible. Since plugging 
leukocytes are characteristic for microvascular 
no-reflow after global ischemia our data suggest 
that the perfusion deficits in parenchymal 
microvessels observed in the current study are 
most likely not a consequence of global post-
hemorrhagic ischemia. Further studies, however, 
are needed to establish a firm cause-effect 
relationship between pial spasms and loss of 
parenchymal perfusion after SAH.  
Taken together, this is the first study to 
investigate the parenchymal microcirculation after 
SAH in vivo. In addition to a better 
characterization of pial spasms, the main finding 
of our study is that SAH causes a severe loss of 
microperfusion in the brain parenchyma. Since no 
biologically relevant plugging of leukocytes was 
observed, we conclude that the mechanisms 
underlying the loss of parenchymal perfusion are 
spasms of pial arterioles. The current study 
establishes the massive lack of parenchymal 
microperfusion as a likely mechanism for cerebral 
ischemia   observed in SAH patients before the 
occurrence of delayed large artery spasms and 
may thereby pave the way for novel therapeutic 
concepts for treatment of early cerebral ischemia 
following SAH.  
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The role of pericytes on microcirculatory dysfunction after 
subarachnoid hemorrhage
Aim of the study: 
Pericytes are a perivascular cell type that expresses contractile elements186 and covers 
up to 30% of cerebral capillary surface.156 Their ability to constrict and thereby 
potentially control blood flow in the cerebral microcirculation has long been discussed. 
Recent data supports that pericytes are involved in the regulation of vessel diameter 
and blood flow during neurovascular coupling.198 Whether they influence cerebral blood 
flow under pathological conditions is under debate and studies which were performed 
after cerebral ischemia suggest different potential pathomechanisms of pericytes.  
 
In an ultrastructural study pericytes were shown to detach from the endothelium and 
migrate towards the parenchyma after brain hypoxia.207 Perivascular stromal cells that 
migrate upon focal ischemia from vessels into the ischemic tissue might be involved in 
scar formation.205 Furthermore it has been shown that pericyte numbers decline after 
ischemia indicating early death of pericytes in ischemic conditions.198 Last but not least 
pericyte have been shown to constrict after ischemia due to oxidative stress thereby 
inducing capillary narrowing.203 Because one major hallmark of early brain injury after 
SAH is cerebral ischemia, we hypothesized that pericytes may play a crucial role in the 
pathophysiology after SAH.  
 
Pericyte survival was examined by platelet derived growth factor beta (PDGF Rβ) 
staining and revealed that pericytes do not undergo cell death three and 24 hours after 
SAH. Furthermore potential pericyte constriction after SAH and its involvement in the 
formation of microvasospasm was investigated by two-photon microscopy. For that 
purpose a transgenic mouse line which expresses a fluorescent marker under control of 
the neural/glial antigen 2 (NG2) promotor was used.215 Perivascular expression of NG2 
was characterized by immunohistochemistry with different cell markers. NG2+ cells that 
were associated to vessels bigger than 10 µm co-localized with αSMA and confluently 
covered the vessel indicating that these cells are vascular smooth muscle cells. 
Vascular smooth muscle cells co-localized with superficial microvasospasm after SAH. 
NG2+ cells associated to capillaries co-stained with PDGF Rβ and revealed pericyte 
morphology. Therefore we identify those cells as mid-capillary pericytes. When 
comparing capillary diameter after SAH at sites where pericytes are associated to 
vessels with sites where no pericyte is present no significant difference was found. 
Therefore we conclude that pericytes are not involved in capillary narrowing after SAH. 
Other components of the neurovascular unit will have to be investigated in detail to 
reveal the pathomechanism of capillary narrowing after SAH.  
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Abstract 
Microvasospasms of pial vessels occur after 
subarachnoid hemorrhage in humans as well as 
in mice and are suspected to be involved in the 
development of early cerebral ischemia. The 
underlying pathomechanisms of early vessel 
spasm are not known. In this study we investigate 
the transgenic pericyte reporter mouse line NG2 
DsRed in a model of subarachnoid hemorrhage 
to investigate the role of pericytes in the formation 
of vessel spasms. Vessel diameter in conjunction 
with pericyte location was evaluated by two-
photon microscopy. 
The expression of the red fluorescent protein 
(DsRed) under the neural/glial antigen 2 (NG2) 
promotor was characterized by 
immunohistochemistry for different cell markers. 
Pericyte survival and migration was investigated 
three and 24 hours after subarachnoid 
hemorrhage by staining for platelet derived 
growth factor receptor β.  
NG2+ cells covering arteries and arterioles 
express α-smooth muscle actin and are negative 
for pericyte markers suggesting that these cells 
are vascular smooth muscle cells. NG2+ cells 
located on capillaries express platelet derived 
growth factor receptor β and are therefore 
presumably pericytes. Cell counts of NG2+ cells 
at three and 24 hours after subarachnoid 
hemorrhage did not reveal pericyte death or 
migratory behavior in the cortex, hippocampus or 
striatum. Arterioles as well as capillaries showed 
a significantly reduced vessel diameter three 
hours after subarachnoid hemorrhage. 
Constricted arterioles were covered with vascular 
smooth muscle cells. The capillary vessel 
diameter however was continuously narrowed 
and constrictions were not restricted to sites 
where NG2+ cells were located.  
We conclude that the localization and the viability 
of pericytes are not altered three and 24 hours 
after subarachnoid hemorrhage. Arterioles as well 
as capillaries exhibit a reduced vessel diameter 
after SAH. Pericytes however do not seem to be 
involved in the formation of capillary spasm after 
SAH. 
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Introduction: 
Subarachnoid hemorrhage (SAH) is a devastating 
subtype of stroke that is associated with a high 30 
days mortality. 21% of case fatalities occur within 
24 hours after the bleeding.1 Early brain injury 
describes acute pathological consequences of 
the bleeding into the subarachnoid space. They 
are multifactorial and induced by increased 
intracranial pressure (ICP), cerebral ischemia, 
brain edema, early cell death and inflammatory 
processes.2 Early cerebral ischemia predicts the 
24 hour mortality in a rat SAH model3 and 
negatively influences three-month outcome of 
SAH patients.4 The underlying mechanisms of 
early cerebral ischemia are not clear to date. 
Pearl-string like constrictions of superficial 
arteries arise in humans5, 6as well as in mice7, 8 
early after SAH. In the SAH mouse model 
superficial microvasospasms are present from 
three to 72 hours after the bleeding and induce 
microthrombosis in pial vessels.7 Moreover a 
subsequent reduction of blood flow velocity as 
well as deep parenchymal cerebral perfusion 
deficits are related to microvasospasms. To date 
the underlying pathophysiology of acute vessel 
spasm formation is not clear. The extravasated 
subarachnoid blood is suspected to play a role in 
the development of arteriolar spasm. Imaging 
data in humans indicate that early ischemia after 
SAH is more pronounced in regions which are in 
close proximity to the aneurysm rupture.9 It is 
suggested that free hemoglobin that is released 
into the subarachnoid space scavenges nitric 
oxide (NO), an endothelial vasodilator. A 
reduction of endothelial NO leads to a vessel 
narrowing that can be resolved by the application 
of a NO donor.10 
Whether also capillaries in the parenchyma, 
which do not come in direct contact with 
subarachnoid blood, constrict in response to SAH 
is not clear. The cell type of the neurovascular 
unit that may induce spasm at the level of the 
capillaries are contractile pericytes. Increasing 
evidence indicates that pericytes regulate 
capillary diameter in health and disease.11 
Pericytes were shown to constrict upon cerebral 
ischemia and thereby hamper blood flow in 
capillaries.12 In this study we aim to investigate 
whether pericytes exhibit a constrictive phenotype 
after SAH and are thereby involved in the 
formation of early cerebral ischemia. 
Therefore we investigate the response of 
pericytes after SAH in vivo. By making use of the 
transgenic pericyte reporter mouse line NG2 
DsRed13 we want to elucidate the contribution of 
pericytes in the formation of microvasospasm. 
Data obtained after cerebral ischemia indicate 
that pericytes exhibit a migratory phenotype 
towards the ischemic lesion and contribute to 
scar formation.14 Therefore we also aim to 
investigate migratory and cell death behavior of 
pericytes in response to SAH.  
The identification of the role of pericytes will help 
to further characterize the pathophysiology of 
early cerebral ischemia after SAH. 
Material and Methods: 
Animals and experimental groups 
In this study a transgenic reporter mouse line was 
investigated in an experimental setup for two-
photon microscopy after SAH. The NG2 DsRed 
mouse line13 is used for the visualization of 
pericytes and vascular smooth muscle cells 
(VSMC). Mice were obtained from the Jackson 
Laboratory and thereafter bred heterozygously on 
a C57Bl6 background. Experiments are approved 
by the Government of Upper Bavaria. 
Histological analysis 
Brains of heterozygous transgenic NG2 DsRed 
mice were extracted after perfusion and 
incubated in 4% PFA at 4°C over night. Brains 
were embedded in 2% agarose and sectioned 
with a vibratome (Leica, Germany) in 50 μm thick 
slices. Slices were collected in a cryoprotectant 
solution (50% 0.1 phosphate buffered saline 
(PBS), 25% glycerol, 25% polyethylenglycol) for 
long-term storage at -20°C. Before staining the 
sections were washed for three days in PBS at 
4°C to remove cryoprotectant solution. Staining 
was performed for NeuN (MAB377 Millipore, 
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Darmstadt, Germany), glial fibrillary acidic protein 
(GFAP) (3670, Cell Signaling, USA), aquaporine 
4 (AB 2218 Millipore, Darmstadt, Germany), 
platelet endothelial cell adhesion molecule 
(CD31) (BM4086 Acris, Germany), α smooth 
muscle actin (αSMA) (CP47 Novus, USA), 
desmin (MAP3430 Millipore, Darmstadt, 
Germany) and platelet derived growth factor 
receptorβ (PDGF Rβ) (3169 NEB, USA). Sections 
were blocked for one hour at room temperature in 
a blocking solution (3% bovine serum albumin, 
0.5% glycine, 0.5% triton). Incubation of primary 
antibody was at 4°C over night in blocking 
solution. Sections were washed and incubated in 
the secondary antibody in blocking solution for 
two hours at room temperature. Alexa Fluor 488 
and Cy3 conjugated AffiniPure (Jackson) 
secondary antibodies were chosen according to 
the species of the primary antibody. Sections 
were mounted in Vectashield DAPI mounting 
medium (Vector Labs, USA) for histological 
analysis. Microscopy of free-floating sections was 
performed with an Imager 7 fluorescent 
microscope (Zeiss, Germany). Confocal 
microscopy was performed with a LSM 7 confocal 
microscope (Zeiss, Germany). 
Pericyte count after SAH 
Free floating sections of NG2 DsRed mice three 
hours after SAH or sham surgery were stained 
according to the protocol described above for 
PDGF Rβ. Images for cell counts were captured 
with a 20x objective. Four regions of interest 
(ROI) in the cortex, two ROI in the hippocampus 
and two ROI in the striatum were analyzed in two 
coronal slices of each animal. Cells were counted 
with Image J software (NIH, USA). 
Two coronal slices of free floating sections of 
C57Bl6 mice 24 hours after SAH or sham surgery 
were collected. The vasculature was stained with 
FITC lectin and pericytes with PDGF Rβ 
according to the protocol described above. 
Pericyte cell counts were performed as described 
for the three hour group.  
 
SAH/sham surgery 
SAH and sham surgery was performed as 
described previously.15 After anesthesia induction 
with isoflurane mice were anesthetized with a 
mixture of 0.05 mg/kg fentanyl (Janssen-Cilac, 
Neuss, Germany), 0.5 mg/kg medetomidine 
(Pfizer, USA) and 5 mg/kg midazolam (Braun, 
Germany). Mice received a preoperative 
analgesia of 4 mg/kg carprofen (Pfizer, USA) 
subcutaneously. They were intubated and placed 
on a feedback regulated heating pad. A laser 
Doppler probe (Periflux 5000, Perimed, Sweden) 
was glued on the temporal bone. An ICP sensor 
(Codman, Johnson & Johnson, UK) was 
implanted under the temporal bone in the epidural 
space. For SAH/sham induction a stiff prolene 5-0 
filament was inserted into the external carotid 
artery and advanced to the Circle of Willis via the 
internal carotid artery. At the bifurcation of the 
middle cerebral artery the Circle of Willis was 
perforated and a bleeding into the subarachnoid 
space was induced. Sham surgery was 
performed accordingly except that the vessel wall 
was not perforated. Animals were monitored for 
physiologic parameters 20 minutes post 
hemorrhage. After suturing anesthesia was 
antagonized by subcutaneous injection of 1.2 
mg/kg naloxone (Actavis, Ireland, USA), 0.5 
mg/kg flumazenil (Inresa, Germany) and 2.5 
mg/kg atipamezol (Pfizer, USA). 
Two-photon microscopy 
First a thinned skull window preparation was 
performed as described previously.16 Therefore 
the left hemisphere of the skull was exposed and 
major branches of the MCA were identified. After 
topic application of lidocaine (2% HCl) the skull 
over the parietal cortex was thinned. During 
drilling the bone was cooled continuously to 
prevent heat damage.  
Two-photon microscopy was performed with a 
LSM 7 (Zeiss, Germany), equipped with a Li:Ti 
laser (Chameleon, Coherent, USA), as described 
previously.17 Briefly anesthetized animals were 
intubated and mechanically ventilated (Minivent 
845, Hugo Sachs, Germany). The endexpiratory 
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pCO2 was measured by microcapnography 
(Model 340, Hugo Sachs, Germany). Animals 
were placed on a feedback controlled heating pad 
to maintain a body temperature of 37°C. Heart 
rate and peripheral oxygen saturation were 
measured on the hind paw by a pulsoximeter 
(MouseSAT, Kent Scientific, USA). The mouse 
was mounted in a nose clamp (David Kopf 
instruments, USA) and transferred to the 
microscope. Z stacks of 4 randomly chosen ROI 
were performed as follows: Fluorescence 
emission was captured with 20x water immersion 
objective (Plan Apochromat, NA 1.0 Zeiss, 
Germany) and GaAsP-NDD detectors for green 
(500-550 nm band pass) and red fluorescence 
(565-610 nm band pass). Z stacks of vessels and 
pericytes were obtained by scanning an area of 
609 x 609 μm with a step distance of 1 μm. The 
depth of z-stacks varied due to window 
preparation and ranged from 250 to 400 μm. 
Laser power did not exceed 10% at the brain 
surface and was adjusted in deeper brain areas. 
For the second imaging session the left femoral 
artery was catheterized using standard 
techniques. Fluoreszeinisothiocynate (FITC) 
dextran (0.5% in saline, Sigma Aldrich, USA) was 
injected to visualize the perfused vasculature. 
Imaging of the four ROIs was performed as 
described above. 
Figure 1 
A 3D vessel reconstruction of two-photon microscopy. Superficial 
arteries are completely covered with NG2+ cells. 42% of perivascular 
NG2+ cells in the parenchymal microcirculation are associated to 
capillary bifurcations. B Quantification of NG2+ cells in arteries, 
venules, pial and parenchymal capillaries. Data represent mean 
number of NG2+ cell bodies along vessel segments of 100 μm length.  
Data analysis 
Images of NG2 DsRed mice were analyzed for 
vessel diameter with Image J software (NIH, 
USA) as follows: Vessels were categorized in five 
different groups depending on their size before 
SAH induction (artery diameter 40-30µm, artery 
diameter 30-20 μm, arteriole diameter 20-15 μm). 
Vessels with a diameter of 40-15 μm were 
defined as arteries and arterioles. These vessels 
exhibited a confluent coverage with NG2+ cells. 
Venules were not measured. Vessels with a 
diameter of 15-5 μm have intermittent coverage 
with DsRed+ cells and were regarded as 
capillaries. The outer diameter of vessels 
represented by red signal was measured 
randomly at nine locations within each ROI before 
and after SAH. The diameter of capillaries was 
measured three times along two vessel segments 
in each ROI after SAH. The first measurement 
was proximal to the pericyte, the second was at 
the location of the pericyte and the third was 
distal to the pericyte (Fig. 7B).  
Statistical analysis 
Data are given in mean ± standard deviation 
(SD). Statistical tests were performed with 
SigmaPlot 12.0 software package (Systat 
Software Inc, USA). 
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Figure 2 
Immunohistological characterization of NG2+ cells. Red fluorescent signal shows transgene expression in heterozygous animals. Green staining 
depicts immunohistochemical staining of different cell markers. Pericytes are located at the parenchymal side of CD31 + endothelial cells. There is 
no colocalization with NeuN (data not shown), desmin or GFAP. Astrocytic endfeet (aquaporin 4) are covering NG2+ cells from the parenchymal 
side. NG2+ cells around arteries co-localize with αSMA. NG2+ cells in the microcirculation co-localize with PDGF Rβ. 
For normally distributed data the paired t-test was 
used to test differences between groups. 
Differences between groups were interpreted 
statistically significant at a p value < 0.05. 
Results 
Histological characterization NG2 DsRed 
The perivascular expression of NG2 in the 
transgenic mouse line NG2 DsRed has not been 
described in detail. Therefore we counted NG2+ 
cells along a vessel distance of 100 μm. Cell 
counts were performed in z stacks obtained by 
two-photon microscopy. Venules, arterioles and 
capillaries can easily be distinguished by blood 
flow direction and vessel branching pattern. 
Arteries have the highest coverage with NG2+ 
cells. The vessels are encompassed with a 
confluent red fluorescent signal. In order to count 
single cells, free floating sections were stained  
with DAPI for visualization of nuclei. Nuclei of red 
fluorescent cells were counted along a vessel 
length of 100 μm. Coverage of NG2+ cells was 
highest in arterioles with an average of 5.9 cells 
per 100 μm vessel length. Penetrating arterioles 
were similarly covered with NG2+ cells. Pial and 
parenchymal capillaries had a comparable 
coverage with NG2+ cells of 1.4 cells per 100 μm 
vessel length. 42% of parenchymal NG2+ cells 
were located at capillary bifurcations. NG2+ cells 
were rarely associated to venules; a vessel 
segment of 100 μm exhibits in average 0.8 NG2+ 
cells (Fig 1A and B). 
In order to identify the cell types which are 
expressing NG2, co-staining with established 
markers of the neurovascular unit were 
performed in NG2 DsRed sections. NG2+ cells 
were negative for CD31, NeuN, GFAP, aquaporin 
4 and desmin (Fig 2). αSMA co-localized with 
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NG2+ cells that surround bigger vessels. We 
regard them as VSMC due to their location along 
the vascular tree and co-localization with αSMA. 
NG2+ cells associated to capillaries consistently 
expressed PDGF Rβ. The immunohistological 
characterization indicates that NG2+ cells 
associated to capillaries are mid-capillary 
pericytes. 
Pericyte survival after SAH 
Pericyte survival was investigated histologically 
three and 24 hours after SAH. Sections from 
SAH/sham experimental animals were stained for 
vessel lumen, PDGF Rβ and DAPI (Fig 3A). 
PDGF Rβ+ and DAPI+ cells were counted in the 
cortex, hippocampus and striatum. In average 15 
to 30 cells per ROI expressed PDGF Rβ+. Cell 
counts did not differ significantly between the 
SAH and sham surgery group (Fig 3B and C). 
The data shows that pericytes do not undergo 
apoptosis or necrosis within the first 24 hours 
after SAH. Furthermore pericytes at 24 hours 
after SAH are still associated to vessels, 
indicating that pericytes do not migrate away from 
vessels early after SAH. 
 
 
Figure 3 
A Representative PDGF Rβ, FITC lectin and DAPI staining of free 
floating sections 24 hours after SAH and sham surgery. PDGF Rβ+ and 
DAPI+ cells were regarded as pericytes. B Quantification of pericytes in 
the cortex, hippocampus and striatum 3 h after SAH/sham surgery. 
Data points represent mean number of PDGF Rβ+, NG2+ and DAPI+ 
cells per ROI. There is no statistically significant difference between the 
SAH and sham surgery group. C Quantification of pericytes (PDGF Rβ+ 
cells) in the cortex, hippocampus and striatum 24 hours after 
SAH/sham surgery. There is no statistically significant difference 
between the SAH and sham surgery group. 
Physiological monitoring 
The ICP was recorded during SAH/sham 
induction and 20 minutes thereafter to confirm 
standardized SAH induction (Fig 4A). During SAH 
the ICP rose to values close to the systemic 
blood pressure and declined within five minutes 
after the bleeding to values between 20 and 30 
mmHg. In the sham surgery group ICP stayed at 
four mmHg during the observation time. Cerebral 
blood flow was measured by laser Doppler 
flowmetry (Fig 4B). Regional cerebral blood flow 
(rCBF) values showed a severe drop in cerebral 
blood flow during bleeding induction. Reperfusion 
was variable. rCBF stayed constant in the sham 
surgery group for the observation time of 20 
minutes. This indicates that SAH/sham surgery 
was performed in a standardized way and that 
the potentially variant genetic background of the 
transgenic mouse line does not have an impact 
on the SAH model. 
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Figure 4 
A ICP values during SAH/sham surgery are depicted in mmHg. SAH 
induction induces mean peak ICP values of 84 mmHg. In sham 
operated animals the ICP stays at four mmHg throughout the 
procedure. B rCBF is depicted in % of initial values. Vessel perforation 
induces a reduction of cerebral blood flow to 14% whereas sham 
surgery does not induce a drop of rCBF. 
 
 
Figure 5 
Schematic sketch shows the area where two-photon microscopy is 
performed. Example of z stack of a NG2 DsRed mouse with 
intravascular FITC dextran. 
Microvasospasm and pericytes 
The outer vessel diameter was measured in z 
stacks before and after SAH and sham surgery 
(Fig 6A). Arterioles have a mean vessel diameter 
reduction of 8% (Fig 6B). Arterioles that 
constricted were covered continuously with NG2+ 
cells. This finding supports that VSMC play a role 
in the formation of superficial microvasospasm 
after SAH. Capillaries revealed a mean vessel 
diameter reduction of 5% compared to baseline 
(Fig 6B). The data on capillary diameter shows 
for the first time that also capillaries constrict in 
response to SAH. The degree of constriction is 
less pronounced than in arterioles. A differential 
measurement of vessel diameter after SAH at 
locations where pericyte cell bodies were located 
compared to vessel segments between pericytes 
elucidated the role of pericytes in capillary 
narrowing (Fig 7A). Vessel diameter did not differ 
between locations where pericyte cell bodies 
were located compared to vessel segments 
proximal or distal to that pericyte (Fig 7B). This 
finding indicates that capillary narrowing after 
SAH is not induced by pericyte constriction. 
Discussion 
In this study we studied the role of pericytes in 
early cerebral ischemia after SAH. In order to 
visualize pericytes we investigated the transgenic 
pericyte reporter mouse strain NG2 DsRed. 
Expression of DsRed under the NG2 promoter 
was characterized by immunohistochemistry of 
perivascular cells, indicating that VSMC and 
pericytes express NG2. Furthermore pericyte 
survival was investigated at three and 24 hours 
after SAH. PDGF Rβ+ cell numbers did not differ 
significantly between SAH and sham surgery. 
Importantly PDGF Rβ+ cells were still located in 
vessel proximity at 24 hours after the bleeding 
indicating that pericytes do not migrate in 
response to SAH. The involvement of VSMC and 
pericytes in the formation of microvasospasm 
after SAH was investigated in vivo. Arteries as 
well as capillaries showed a significant reduction 
in vessel diameter three hours after SAH. 
Constricted arterioles were continuously covered 
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with NG2+ cells. Therefore NG2+, αSMA+ 
perivascular cells probably mediate arteriolar 
constriction. Constriction of capillaries however 
was not restricted to locations where pericyte cell 
bodies were located. We conclude that pericytes 
do not induce capillary microvasospasm after 
SAH. 
 
Figure 6  
A Representative 3D projection of a two-photon microscopy z stack. 
The left image shows a native picture. The diameter of the vessel is 
clearly outlined. Big solitary superficial NG2+ cells were associated to 
remaining bone. The right image shows the same ROI after SAH with 
green plasma dye (FITC dextran). B Quantification of the outer vessel 
diameter before and after SAH. The vessel diameter of arterioles and 
capillaries was measured before and after SAH. After SAH the vessel 
diameter was significantly reduced. Arterioles showed a mean vessel 
diameter reduction of 8% and capillaries show mean vessel diameter 
reduction of 5%. 
Role of genetic background 
The NG2 DsRed transgenic mouse line was used 
for investigations of pericyte involvement in the 
formation of vessel spasm after SAH. The mouse 
line was bred heterozygously on a C57Bl6 
background; however a genetic shift can always 
induce an altered phenotype compared to wild 
type animals. Therefore it is important that the 
animal model produces robust and stable findings 
also in genetically modified mouse strains. 
Physiological data that were captured during SAH 
surgery were comparable to physiological data 
obtained from C57Bl6 animals.18 This supports 
that the obtained data are valid and can be 
interpreted in conjunction with previously 
obtained results. Furthermore the data suggest 
that the pathophysiology of vessel spasm is 
robust and alike in different transgenic mouse 
lines. 
Characterization of NG2+ cells 
The identification of pericytes based on 
immunohistochemical staining is difficult because 
none of the known pericyte markers is specific.19 
The definition of a pericyte is mainly 
morphological: pericytes are perivascular cells 
that are located in the same basement membrane 
with the endothelium.20 This characteristic feature 
however can only be studied on a structural level 
by electron microscopy. In this study the 
identification problem is circumvented by looking 
at cell localization within the vascular tree in 
combination with expression of cell markers. A 
confluent layer of VSMC surrounds arteries and 
arterioles which consistently express αSMA.21 At 
the capillary level the so called mid-capillary 
pericytes are located which are known to express 
PDGF Rβ and NG2.19 Therefore co-staining in 
combination with perivascular vessel localization 
makes the identification of cerebral pericytes and 
VSMC possible. We regard NG2+ cells that cover 
arterioles and express αSMA as VSMC and NG2+ 
cells that are associated to capillaries and 
express PDGF Rβ as pericytes. 
Pericyte numbers after SAH 
A study that investigated the reaction of pericytes 
to hypoxic condition showed that pericytes 
migrate away from vessels immediately after 
onset of hypoxia.22 In a stroke model pericytes 
were found to detach from the vessel and migrate 
toward the ischemic injury. These cells gather a 
microglial phenotype and are suspected to be 
involved in scar formation.14 Similarly in the spinal 
cord pericytes have been shown to migrate and 
participate in scar formation.23 In order to 
investigate the migratory behavior of pericytes 
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after SAH vessel lumen and pericytes were 
stained 24 hours after SAH and sham surgery. 
No significant difference in pericyte numbers 
along cerebral vessels was found when 
comparing SAH and sham condition. This 
indicates that pericytes do not migrate in 
significant numbers away from the capillaries 
within 24 hours after SAH. The finding however 
does not confirm previous findings that showed 
early pericyte migration in hypoxic condition. One 
explanation for this conflicting finding might be 
that the resolution of the obtained images was too 
low to detect small changes in pericyte position. 
Therefore pericyte location in relation to vessels 
after SAH might be reinvestigated by electron 
microscopy or high resolution microscopy 
techniques. 
Another suggested reaction of pericytes to 
cerebral ischemia is early cell death.11 In order to 
investigate pericyte survival following cerebral 
hemorrhage we counted the numbers of PDGF 
Rβ+ cells three and 24 hours after SAH. Pericyte 
survival was not affected within 24 hours after the 
bleeding. This finding can be explained by the 
different pathophysiology of ischemic and 
hemorrhagic stroke. In the ischemic core of focal 
ischemia energy depletion is much more 
pronounced and leads to widespread apoptosis 
and necrosis. In SAH however apoptosis is 
sporadic and distributed in hippocampus and 
cortex.24 The metabolic derangement is milder 
than in ischemic tissue. This difference might 
explain the differential findings on pericyte 
migration and survival between stroke and SAH. 
 
 
 
Figure 7 
A Representative measurement of capillary diameter at locations 
where pericytes are present compared to locations where no pericyte is 
present. B Quantification of vessel diameter in relation to pericyte 
location. There is no statistically significant difference between the 
capillary lumen at sites of pericytes compared to vessel segments 
which are devoid of pericytes. 
Pericytes and microvasospasm 
After ischemia pericytes have been shown to 
constrict and thereby narrow capillary lumen.12 
The pathophysiologic assumption was that 
energy depletion induces passive pericyte 
constriction in analogy to rigor mortis observed in 
skeletal muscle.11 Pericyte constriction was 
shown to induce a narrowing of the vessel lumen 
at sites where pericyte bodies are located. The 
narrowing may hamper blood flow and leads to 
microcirculatory perfusion deficits. Subsequently 
pericytes are suspected to undergo cell death. 
We investigated pericyte constriction after SAH, 
because metabolic derangement also occurs in 
the hemorrhagic subtype of stroke.25 However no 
focal constrictions of capillaries at sites where 
pericytes were located were found. This finding 
supports that pericytes do not directly induce 
capillary narrowing after SAH. Therefore we could 
not confirm constriction of pericytes in 
hemorrhagic stroke.  Long processes of mid-
capillary pericytes may make the correct 
identification of cell dimensions difficult. However 
in NG2 DsRed mice also the processes of  
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pericytes contain red fluorescent dye. Thus we 
specifically identified vessel segments that were 
devoid of pericyte cell bodies as well as their 
processes. In summary our data show that 
pericytes do not play a significant role in the  
pathophysiology of early cerebral ischemia after 
SAH. VSMC however, are probably the cells 
which induce microvasospasm of arteries on the 
brain surface. 
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In vivo Ca2+- imaging in cerebral endothelial cells
Aim of the study: 
In order to investigate functional Ca2+ levels in endothelial cells we used a transgenic 
mouse line that expresses the ratiometric Ca2+ probe TN-XXL under the promotor of 
chicken β-actin.216 The probe is composed of the two fluorescent proteins: the yellow 
fluorescent protein citrine and cyan fluorescent protein (CFP) that are coupled by a Ca2+ 
sensitive peptide derived from troponin C. A change of Ca2+ concentration leads to a 
conformation change that induces a Föster resonance energy transfer between both 
fluorescent proteins and thereby a change of their fluorescence intensity.217 In the brain 
the sensor is primarily expressed in the vasculature. We confirmed expression of TN-
XXL in endothelial cells by immunohistochemistry for different cell markers. Functional 
two-photon microscopy was performed under baseline condition and three hours after 
SAH or sham surgery. Citrine to CFP ratio revealed a small standard deviation under 
baseline condition. No bleaching or diffusion of the sensor was detected between the 
imaging sessions. Three hours after SAH the ratio of citrine to CFP was reduced 
indicating decreased Ca2+ concentration in endothelial cells.  
A reduction of blood flow velocity may lead to reduced intracellular Ca2+ concentration 
mediated by a drop of shear stress on the endothelium. Shear stress triggers a certain 
level of intracellular Ca2+ concentration218 that might mediate physiological vascular tone 
via nitric oxide signaling.  
However the finding needs to be interpreted cautiously because two potential 
confounding factors were identified: The ratio may artificially be shifted by auto 
fluorescence of subarachnoid blood that is located around superficial vessels after SAH. 
A second confounding factor is that pH in endothelial cells may be decreased in 
ischemic condition, which may induce a selective quenching of citrine fluorescence.219  
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Abstract 
Introduction 
Cytosolic Ca2+ concentration is an important 
component of intracellular signaling and a 
sensitive marker for cell activation. Repetitive in 
vivo measurements of cytosolic Ca2+ 
concentration is challenging and therefore not 
studied in detail in cerebrovascular cells. 
Therefore the aim of this study was to investigate 
whether a transgenic mouse line expressing the 
ratiometric Ca2+ dye TN-XXL under the promotor 
of chicken β-actin can be used for this purpose.  
Methods 
Cellular expression of TN-XXL in the brain was 
characterized by immunohistochemistry. 
Cytosolic Ca2+ concentration was measured by 
two-photon microscopy under native condition 
and three hours after subarachnoid hemorrhage 
or sham surgery.  
 
 
Results 
Expression of TN-XXL was highest in cerebral 
endothelial cells and also detectable in cortical 
neurons. The citrine to cyan fluorescent protein 
ratio was robust under native condition and after 
sham surgery. Cerebral endothelial cells 
exhibited a decreased citrine to cyan fluorescent 
protein ratio three hours after subarachnoid 
hemorrhage, suggesting decreased intracellular 
Ca2+ levels in endothelial cells. 
Conclusion 
The TN-XXL transgenic mouse line is suitable to 
measure cytosolic Ca2+ in cerebrovascular 
endothelial cells in vivo under physiological and 
pathological conditions. Endothelial dysfunction 
after subarachnoid hemorrhage may be induced 
by reduced intracellular Ca2+ levels. 
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Introduction 
The transgenic mouse line CAG TN-XXL was 
designed for chronic in vivo studies of functional 
Ca2+ imaging. Mice express the ratiometric Ca2+ 
probe TN-XXL under the promotor of chicken β-
actin (CAG).1 The Ca2+ probe is composed of the 
yellow fluorescent protein citrine cp174, which is 
coupled to a cyan fluorescent protein (CFP) by a 
troponin C analogue that has been optimized for 
physiological Ca2+ concentrations.2 Changes in 
intracellular Ca2+ levels lead to a conformation 
change of the sensor thereby inducing a Förster 
resonance energy transfer (FRET) from CFP to 
citrine.3 Shift of fluorescence intensity is 
independent of the concentration of the probe, a 
prerequisite for reliable repetitive measurements 
in vivo.2 CAG TN-XXL mice express the Ca2+ 
probe theoretically in all cells of the body. So far, 
however, the vascular expression of TN-XXL in 
the brain has not been characterized in detail. 
Investigations of TN-XXL fluorescence in the 
brain suggest that the probe is predominantly 
found in the vasculature and to a lesser extent in 
neurons.1 Which cells of the vessel wall express 
TN-XXL is of particular importance since 
repetitive measurements of intracellular Ca2+ 
concentrations in cerebrovascular cells have not 
been possible in vivo.  
In order to study changes of cerebrovascular Ca2+ 
concentrations under pathological conditions we 
investigated the CAG TN-XXL mouse line in a 
model of subarachnoid hemorrhage (SAH). 
Cerebral ischemia is an important component of 
the early pathophysiology after SAH.4 The 
mechanism that is causing cerebral ischemia 
after SAH is not known to date; suggested 
pathomechanisms for early cerebral ischemia 
after SAH are microvasospasm5 and endothelial 
dysfunction;6 both conditions that are associated 
with changes in intracellular Ca2+.  
Therefore the aim of the current study was to 
identify the vascular cell type which expresses 
TN-XXL in the brain and to investigate functional 
Ca2+ signaling in the vasculature in a mouse 
model of SAH.  
Methods 
Animals and experimental groups 
In this study we investigated the CAG TN-XXL 
mouse strain by two-photon microscopy. Mice 
express the ratiometric Ca2+ probe TN-XXL under 
the chicken β-actin promoter with broad 
expression.1 Experimental animals were 
randomly chosen and assigned to the sham and 
SAH group during surgery. Mice were group 
housed and always had access to food and 
water. Experiments are approved by the 
Government of Upper Bavaria.  
Free floating immunohistochemistry 
Paraformaldehyde (PFA) perfused and postfixed 
(24 hours) brains were sectioned with a 
vibratome (Leica, Germany). 50 μm sections 
were collected and stored in cryoprotectant 
solution (50% 0.1 phosphate buffered saline 
(PBS), 25% glycerol, 25% polyethylenglycol) until 
immunohistochemical staining. CAG TN-XXL 
sections were stained for NeuN (MAB377 
Millipore, Darmstadt, Germany), aquaporine 4 
(AB 2218 Millipore, Darmstadt, Germany), 
platelet endothelial cell adhesion molecule 1 
(CD31) (BM4086 Acris, Germany), α smooth 
muscle actin (αSMA) (CP47 Novus, USA), 
desmin (MAP3430 Millipore, Darmstadt, 
Germany) and platelet derived growth factor beta 
(PDGF Rβ) (3169 NEB, USA). Sections were 
washed in PBS three days for removal of 
cryoprotectant. After incubation in blocking 
solution (3% bovine serum albumine, 0.5% 
glycine, 0.5% triton) for one hour the primary 
antibody was incubated at 4°C over night. After 
washing with PBS the respective secondary 
antibody (Alexa Fluor 488 and Cy3 conjugated 
AffiniPure, Jackson) was incubated at room 
temperature for two hours. Sections were 
mounted on slides and embedded in Vectashield 
DAPI mounting medium (Vector Labs, USA). 
Microscopy of free floating sections was 
performed with a LSM 7 (Zeiss, Germany) 
confocal microscope.  
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SAH and respective sham surgery 
SAH and respective sham surgery were 
performed as described previously.7 After 
isoflurane induction animals were anesthetized 
with a combination of 0.05 mg/kg fentanyl 
(Janssen-Cilac, Neuss, Germany), 0.5 mg/kg 
medetomidine (Pfizer, USA) and 5 mg/kg 
midazolam (Braun, Germany). Animals received 
preoperative analgesia of 4 mg/kg carprofen 
(Pfizer, Germany). They were intubated, 
ventilated and placed on a feedback controlled 
heating pad. Peripheral oxygen saturation and 
heart rate were measured on the hind paw. SAH 
was induced by endovascular vessel perforation 
at the Circle of Willis. A prolene 5-0 filament was 
inserted into the external carotid artery and 
advanced to the skull base via the internal carotid 
artery. Vessel perforation at the skull base was 
indicated by a sharp rise of intracranial pressure 
(ICP) and a simultaneous drop of cerebral blood 
flow (CBF). After vessel perforation animals were 
monitored for another 20 minutes before they 
received antagonisation of anesthesia (s.c. 1.2 
mg/kg naloxone (Actavis, Ireland, USA), 0.5 
Figure 1 
Immunohistological characterization of perivascular TN-
XXL expression in free-floating brain sections (50 µm). 
TN-XXL expression is shown in green and respective 
immunohistological staining in red. A TN-XXL co-
localizes with the endothelial marker CD31.  B Less 
intense co-localization is found with the neuronal 
marker NeuN. αSMA staining of VSMC surrounds TN-
XXL expression towards the parenchyma. PDGF Rβ 
does not co-localize with TN-XXL. C Expression of TN-
XXL in a native brain section and enhanced TN-XXL 
expression in a penetrating arteriole. 
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mg/kg flumazenil (Inresa, Germany) and 2.5 
mg/kg atipamezol (Pfizer, USA)). 
Two-photon microscopy 
After topic application of lidocaine (2% HCl) a 
thinned skull window preparation was performed 
as described previously.8 Z stacks (1 µm step 
distance) of four randomly chosen regions of 
interest (ROI) (609 x 609 µm) were obtained with 
a fixed laser power that did not exceed 20% (Fig 
2). The initial scan and vessel imaging three 
hours after SAH were obtained with the same 
settings in each ROI. Excitation wavelength was 
840 nm and fluorescence was detected with 
GaAsP-NDD detectors for yellow (520-560 nm 
band pass) and blue (460-500 nm band pass) 
fluorescence. After microscopy mice were 
transcardially perfused with 20 ml natural saline 
and 20 ml 4% PFA and brains were kept for 
histological examinations.  
 
 
 
Figure 2 
Experimental setup in vivo imaging. The area where vessels were 
investigated is indicated in a schematic skull drawing. 4 ROI were 
imaged before and after SAH. Pictures show examples of citrine and 
CFP fluorescence in the vasculature. 
Data analysis 
Images of CAG TN-XXL were analyzed for 
intensity of citrine and CFP with Image J software 
(NIH, USA) as follows: In each ROI three different 
vessel locations were chosen for analysis. Grey 
value measurements were selected by free hand 
drawing. If applicable the same shape of 
measurement was used before and after 
SAH/sham surgery. The mean grey value of the 
chosen region was measured in the blue and the 
yellow channel before and after SAH/sham. For 
background determination the vessel lumen was 
selected by free hand drawing when applicable. 
When vessel volume was too small a neighboring 
parenchymal area was chosen. The ratio of 
citrine to CFP signal was calculated for the same 
selected areas. A systematic bleed through of 
30% from the yellow to the blue band pass filter 
was subtracted. 
Statistical analysis 
Data are given in mean ± standard deviation 
(SD). Statistical tests were performed with 
SigmaPlot 12.0 software package (Systat 
Software Inc, USA).  For pairwise comparison the 
paired student t test was used. Differences 
between groups were interpreted as statistically 
significant at p values < 0.05. 
 
Results 
Histological characterization of CAG TN-XXL 
expression 
The vascular and perivascular expression of TN-
XXL in the brain has not been investigated in 
detail in the chicken β-actin TN-XXL mouse 
strain. In order to identify the cell type that is 
expressing the Ca2+ sensor free floating sections 
of CAG TN-XXL animals were stained with 
established cell markers. TN-XXL does not co-
localize with αSMA and PDGF Rβ (Fig 1). 
Therefore it is not expressed by VSMC, pericytes 
or other vascular mural cells. Also the astrocytic 
endfeet marker aquaporin 4 does not co-localize 
with TN-XXL expression. TN-XXL is co-
expressed with CD31, indicating high TN-XXL 
expression in endothelial cells (Fig 1A). 
Interestingly sensor expression is higher in 
arteries and arterioles than in venules (Fig 4A). 
NeuN+ cells reveal weaker TN-XXL expression 
when compared to vascular expression. The 
findings show that TN-XXL is specifically 
expressed by endothelial cells and neurons. 
In vivo Ca2+- imaging in cerebral endothelial cells 
 
63 
 
Other cerebrovascular cell types do not exhibit 
TN-XXL expression. 
Physiologic parameters during SAH induction 
During SAH induction the ICP and the regional 
CBF were monitored. SAH led to a sharp 
increase of ICP which was accompanied by a 
severe reduction of regional CBF. ICP values 
stabilized at values around 30 mmHg within 5 min 
after the bleeding whereas cerebral reperfusion 
remained impaired (Fig 3A and B).  
 
Figure 3 
A Intracranial pressure measurement during and 20 min after SAH or 
sham induction. SAH leads to an increase of ICP to a mean value of 95 
mmHg. ICP values stabilize at values around 30 mmHg within 5 min 
after the bleeding. Sham surgery does not induce a rise of ICP.  
B Regional cerebral blood flow (rCBF) during SAH induction. SAH 
leads to a sharp decrease of cerebral perfusion and reperfusion is 
variable between animals. Sham surgery does not induce a drop of 
rCBF. 
 
 
Ca2+ signals after SAH 
The citrine to CFP ratio was compared between 
the native condition and after sham or SAH 
surgery (Fig 4A). In native condition the mean 
citrine to CFP ratio was ~0.6. We assume that 
this ratio corresponds with physiologic Ca2+ 
levels. The standard deviation of the ratio was 
small indicating a robust measurement. The 
citrine to CFP ratio after sham surgery did not 
significantly differ from the native condition even 
though the variance was slightly increased. After 
SAH the citrine to CFP ratio was significantly 
decreased compared to the native condition (Fig 
4B). This decrease indicates a low free 
intracellular Ca2+ concentration in endothelial 
cells. However other explanations for this result 
are discussed below. 
 
Discussion 
Expression of TN-XXL 
The TN-XXL Ca2+ probe is expressed under the 
chicken β-actin promoter. β-actin is a gene that is 
theoretically expressed by all cells in the body. 
However TN-XXL expression in this transgenic 
mouse line is abundant in some tissues and other 
tissues and cell types are devoid of the sensor. 
Direnberger et al. report that lymphatic tissues 
including spleen and circulating immune cells do 
not express the sensor. The underlying reasons 
for the differential expression of a transgene 
under the same promotor are not fully 
understood. Expression levels are probably not 
only dependent on the promotor which is flanking 
the transgene but also the insertion site with its 
surrounding transcription factors. Furthermore the 
number of integrated copies of the construct 
influences its expression pattern. Another β-actin 
reporter mouse strain shows little expression in 
neuronal tissue but strong expression in cerebral 
pericytes.9 In the CAG TN-XXL mouse line 
however the sensor is largely confined to 
endothelial cells; weaker expression is found in 
neurons. This makes the CAG TN-XXL mouse 
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line the first model for functional Ca2+ imaging in 
endothelial cells. 
 
 
 
Figure 4 
A Representative pictures show two-photon microscopy 3D projections 
of TN-XXL before and after SAH. TN-XXL is expressed primarily in 
arteries and arterioles. Ratiometric change of fluorescence intensity is 
not detectable by eye. B Quantification of citrine to CFP ratio in native 
condition, after sham and SAH surgery. After SAH but not after sham 
surgery the citrine to CFP ratio is significantly reduced compared to the 
native situation. A reduced citrine to CFP ratio indicates low 
intracellular Ca2+ concentration. 
In vivo Ca2+ imaging  
Native scans between different animals and also 
imaging after sham surgery exhibit a small 
standard deviation of citrine to CFP ratio, 
indicating that endothelial Ca2+ concentrations are 
stable under physiologic conditions (Fig 4B).  
During intravital microscopy neither bleaching of 
the signal during repetitive scans nor leaking of 
the sensor out of endothelial cells was detected. 
These findings show that ratiometric Ca2+ 
measurements under physiologic conditions are 
stable and robust.   
Functional Ca2+ imaging after SAH indicates a 
reduction of endothelial Ca2+ concentration. This 
finding is somewhat surprising and needs to be 
interpreted carefully. However endothelial 
pathophysiology after SAH is potentially linked to 
decreased intracellular Ca2+ levels. The reason 
for decreased endothelial Ca2+ levels may be a 
reduction of blood flow velocity that has been 
shown in superficial arteries after SAH. Under 
physiologic conditions blood flow in vessels 
induces shear stress on the endothelium. Shear 
stress is important for the physiologic vasodilatory 
function of the endothelium and is associated with 
a certain level of intracellular Ca2+.10 Increased 
shear stress induces increased intracellular Ca2+ 
levels.10 Therefore one can assume that a 
reduction of blood flow velocity will in turn lead to 
decreased intracellular Ca2+ levels. 
Decreased intracellular Ca2+ values directly 
interfere with the endothelium mediated 
vasodilation. Endothelial vasodilatory function is 
mediated by the vasodilatory substance nitric 
oxide (NO) which induces dilation of surrounding 
vascular smooth muscle cells (VSMC). NO levels 
have been shown to be reduced early after 
SAH.11 Importantly also the downstream signaling 
pathway of NO, the cyclic guanylatcyclase which 
mediates the vasodilatory effect in VSMC is 
reduced.12 The activity of endothelial nitric oxide 
synthase (eNOS) is Ca2+ dependent; therefore 
decreased Ca2+ levels may lead to a lack of NO 
after SAH. A study investigating the vasodilatory 
effect of tetramethylpyrazine after SAH finds a 
combination of amelioration of vasospasm, 
increased NO and eNOS levels as well as 
increased intracellular Ca2+ in endothelial cells 
upon treatment after SAH.13 This study indicates 
that the NO signaling pathway may be impaired in 
conjunction with decreased Ca2+ levels in 
endothelial cells. This suggested 
pathomechanism will have to be investigated in  
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detail by application of modulators of the NO 
pathway after SAH.  
In addition to changes in endothelial Ca2+ 
concentrations also experimental factors affecting 
the measurement itself may be responsible for 
the observed change in TN-XXL fluorescence. 
One potential confounder is that extravasated 
subarachnoid blood that is located around 
superficial cerebral vessel exhibits 
autofluorescence which interferes with the 
fluorescence of the sensor. However no 
additional perivascular fluorescence was detected 
specifically after SAH during two-photon 
microscopy. Therefore it is not likely that 
extravasated subarachnoid blood directly 
interferes with the measurement. 
A second potential confounding factor might be 
that especially the citrine fluorescence is pH 
sensitive,14 e.g. a drop of pH from 7 to 6.8 
reduces fluorescence emission by 5 to 10%. 
Because of acute energy depletion and acidosis 
after SAH15 a decreased pH in endothelial cells is 
likely. Endothelial cells of parenchymal vessels 
have previously been shown to undergo cell 
death early after the bleeding.16 Therefore the 
citrine to CFP ratio change could also be 
explained by early metabolic dysfunction and 
endothelial cell death early after SAH. 
Accordingly, endothelial viability needs to be 
carefully assessed when using the CAG TN-XXL 
mouse line. 
In conclusion, we characterized cerebrovascular 
CAG TN-XXL expression and identified strong 
expression of the ratiometric Ca2+ sensor in 
endothelial cells in brain sections. These data 
suggest that CAG TN-XXL mice are suitable to 
measure intracellular Ca2+ in endothelial cells in 
the brain. Further experiments will allow to better 
understand the dynamics of endothelial signaling 
in healthy brain and during cerebral ischemia and 
hemorrhage.  
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1. Aims of the study 
 
Cerebral ischemia is an important component of the pathophysiology after 
subarachnoid hemorrhage (SAH), a subtype of stroke with a particularly bad prognosis.3 
For decades it was believed that the mechanisms causing cerebral ischemia after SAH 
were related to delayed spasm of large intracranial arteries, however, within the past 
few years experimental data suggested that disturbance on the level of the cerebral 
microcirculation could be the real source of post-hemorrhagic ischemia.97 The 
underlying pathomechanisms that are causing early cerebral ischemia in SAH patients 
are not fully characterized to date. Among others pearl-string like constrictions of pial 
arteries have been suggested to be causative for early cerebral ischemia after SAH.150  
The first aim of this thesis was to characterize how and to which extent blood flow 
dynamics in the parenchymal microcirculation are affected after SAH. We tested if 
superficial artery constrictions have implications on parenchymal brain perfusion. One 
hypothesis was that vessels in the cortical parenchyma namely penetrating arterioles 
and capillaries constrict in the same manner as pial arteries after SAH. Another 
potential cause for reduced parenchymal vessel perfusion is the plugging of vessels by 
leukocytes that interact with the endothelium.127 Therefore parenchymal vessel diameter 
and leukocyte-endothelium interactions as triggers for reduced parenchymal perfusion 
after SAH were investigated. 
The second aim of the study was to elucidate the role of pericytes in the formation of 
vessel spasm after SAH. The main hypothesis was that vascular smooth muscle cells 
(VSMC) and pericytes are contracting upon SAH and thereby narrow the vessel lumen. 
Another hypothesis was that pericytes die or migrate after SAH and thereby contribute 
to capillary perfusion deficits and the formation of brain edema. These questions were 
addressed by investigating constrictive and migratory behavior of pericytes after SAH.  
The third aim of the study was to characterize the underlying functional 
pathomechanism of vessel spasm after SAH. Therefore the activation status of 
cerebrovascular cells was measured by comparing free intracellular Ca2+ concentration 
before and after SAH. 
 
2. Methodological contribution 
 
To better understand the pathophysiology of SAH a variety of animal models have been 
developed.56 Ideally, these models should resemble SAH in patients as good as 
possible, should be standardized and reproducible. The model which resembles the 
human situation best is the endovascular filament perforation model.213 Since SAH 
induction is microsurgically demanding the adaptation of the perforation model to mice, 
the most commonly used species in SAH research, was challenging. Especially the 
small body size in combination with a small blood volume were obstacles that had to be 
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taken. Thus the endovascular perforation model remained variable and was not 
frequently used in the field. In our laboratory we optimized the endovascular perforation 
model in mice.67, 118 In the first part of the current thesis the SAH mouse model was 
further standardized.64 The JoVE video publication “A murine model of subarachnoid 
hemorrhage” gives instructions for surgical procedures, emphasizes critical steps during 
surgery and gives recommendations for the use of monitoring devices that are 
prerequisites to perform the model in a standardized way. Monitoring of intracranial 
pressure (ICP) and regional cerebral blood flow (CBF) are important to control bleeding 
induction and to make sure that neuronal tissue is not damaged by the intravascular 
filament. When crucial points during surgical SAH induction are considered the model is 
highly reproducible and standardized. In this thesis we report robust physiological 
findings during SAH induction in different transgenic mouse strains. Therefore we 
conclude that the employed SAH mouse model is a standardized and reproducible 
animal model that reveals robust findings in the early phase of SAH.67 
 
For in vivo investigations of cortical microvessels the preparation of a cranial window is 
required. Different techniques for cerebral window preparation have been described:220 
The preparation with the deepest insight into the brain is the glass window preparation. 
A piece of bone is removed and replaced by a glass window. A less invasive cranial 
window preparation technique is the thinned-skull window preparation.221 Here the bone 
is not separated but merely thinned at the imaging position. The bone stays intact and 
the physiologic shape towards the brain surface is preserved. Therefore the anatomical 
unit of bone, dura mater and subarachnoid space is not altered. By this cranial window 
preparation the physiologic pressure situation in the subarachnoid space is preserved 
which allows the normal distribution of subarachnoid blood in a situation of elevated 
ICP. The optimized cranial window allows to image vessels in a native situation as well 
as a comparison of vessel morphology and functional imaging before and after 
hemorrhage. 
 
In previous intravital microscopy studies on blood flow and vascular function after SAH 
pial vessels were visualized by epifluorescence microscopy.150 This technique does not 
enable investigations of parenchymal vessels because of its limited penetration depth. 
Therefore the parenchymal microcirculation could not be studied in detail. The beauty of 
the current experimental setup is that we employed in vivo two-photon microscopy to 
investigate microcirculatory disturbances after SAH. Two-photon microscopy allows 
looking down more than 1mm into the brain tissue.222 Optical sections within a brain 
column are obtained by the scanning of layers. For analysis the image stack can be 
reconstructed in three dimensions to identify large structures like the cerebral 
vasculature. Therefore vessel shape, perfused vessel volume and blood flow velocity in 
the parenchyma can be measured and quantified.  
 
Another methodological improvement is that transgenic animal lines were used to 
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investigate the pathophysiology of SAH. So far SAH studies were only rarely performed 
in transgenic animals because they tend to have a higher standard deviation or may 
reveal a different disease phenotype. The experiments of this thesis were performed in 
mouse lines that were backcrossed to a C57Bl6 background, which means that data 
were obtained from the same genetic background and should therefore be comparable. 
However, especially when animals are bred homozygously for generations without 
refreshment of the background line a genetic shift can occur.223 We therefore obtained 
additional physiological data in order to be able to compare results across different 
experimental groups. No differences neither in the induction of SAH nor in the formation 
of microvasospasm and early cerebral ischemia after SAH were detected. Therefore we 
are confident that results can be interpreted in conjunction across different lines. 
 
3. Discussion of relevant findings 
 
The distribution of extravasated subarachnoid blood after SAH has never been 
investigated in detail in the endovascular perforation mouse model. However the 
extravasated blood in the subarachnoid space is thought to be involved in the early 
pathophysiology after SAH.133 It is suspected to be causative for pearl-string 
constrictions of superficial arteries after the bleeding. Subarachnoid blood stretches 
along brain supplying arteries from the base of the brain to the dorsal cortices. This 
finding is especially crucial for imaging experiments because the region of interest for 
intravital microscopy is located at the dorsal cortex. Therefore in vivo microscopy was 
performed at a location where superficial arteries were covered with subarachnoid 
blood. 
 
By comparing the vessel morphology before and after SAH the identification of a global 
and a bottleneck constriction type in addition to the previously described pearl-string 
constrictions of superficial arteries was possible. These newly identified vessel 
constriction types have implications on the blood flow dynamics after SAH.  
Measurement of blood flow velocity before and after SAH show that blood flow is 
reduced after SAH compared to the sham situation. In combination with a reduced 
vessel diameter it leads to reduced blood volume flowing into the parenchyma via 
penetrating arterioles. When regarding the Hagen Poiseuille law, which takes the radius 
of a tube into the forth power to determine the flow volume, the observed reduction of 
vessel diameter has a big influence on blood flow volume through superficial arteries 
and arterioles. A diameter reduction of 20% is therefore associated with a 60% 
reduction of flow-through-volume. The Hagen Poiseuille law is primarily valid for laminar 
flow through a tube, in a turbulent flow situation the reduction of flow volume is 
expected to be even larger.  
While superficial cerebral vessels reveal several collaterals that can take over tissue 
perfusion in case of vessel narrowing or occlusion penetrating arterioles represent a 
bottleneck in cortical perfusion.131 Even the occlusion of one single penetrating arteriole 
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cannot be fully compensated by collateral blood flow in adjacent penetrating arterioles. 
Subsequently blood flow in parenchymal capillaries that are supplied by the affected 
penetrating arteriole is significantly reduced.131  
Besides blood flow restrictions on the brain surface also dysfunction on the capillary 
level may be responsible for early ischemia after SAH. A potential pathomechanism for 
cerebral perfusion deficits may be the plugging of capillaries by leukocytes that interact 
with the endothelium.127 The number of sticking leukocytes increased five-fold after 
SAH, but the absolute number of sticking leukocytes in the investigated tissue volume 
was too low to explain the observed perfusion deficits in the parenchyma. 
It is likely that the observed reduction of blood flow in the parenchyma is severe enough 
to cause ischemia in brain tissue. Under ischemic conditions oxygen and glucose 
supply is not sufficient to provide cells with metabolites. The result is a metabolic 
derangement which manifests in increased lactate and pyruvate levels after SAH.96 
Cells in a metabolic stress condition may initiate apoptosis or undergo necrosis. 
Apoptosis after SAH is mainly detected in hippocampal neurons and endothelial cells 
and to a lesser extent in cortical neurons.109 Similarly necrosis is found after SAH but 
brain infarction does not occur.224 However a long lasting reduction of cerebral perfusion 
down to values around 30% of initial perfusion would cause widespread brain 
infarction.225 Therefore it is likely that severe cerebral ischemia is not persistent in the 
employed SAH model. Acute ischemia after SAH has probably functional reasons and 
resolves subsequently. Microvasospasm have been shown to be most pronounced 
three hours after the bleeding and become less frequent and severe at 24 and 72 
hours.150 This finding is important for the discussion of potential therapeutic strategies of 
microvasospasm. Treatment has to be initiated early after the bleeding in order to 
prevent neuronal tissue damage. We suggest a therapeutic time frame of maximal 24 
hours after SAH for the resolution of vasospasm and early cerebral ischemia. Our data 
indicate that the therapeutic resolution of superficial artery constriction will also promote 
brain perfusion in the parenchyma. 
 
For the identification of new therapeutic targets in the treatment of acute cerebral 
ischemia after SAH we attempted to identify the cell type that is initiating vessel 
constriction and in a second step to reveal the underlying functional pathophysiology.  
In this thesis a pericyte reporter mouse line was used for investigations on the role of 
pericytes after SAH. Transgenic mice express a red fluorescent protein (DsRed) in 
pericytes, which can therefore be visualized in vivo. One challenge of reporter mouse 
lines is a potential aggregation of a fluorescent dye226 that may disturb the physiology of 
dye expressing cells. In NG2 DsRed mice no aggregation of DsRed in pericytes was 
found. The distribution of the fluorophore was homogeneous in the cytoplasm and 
stretched into cell processes. Another potential problem which may arise when using 
reporter mouse lines is that the expression of the reporter is sometimes unspecific. The 
NG2 DsRed mouse line expresses DsRed under the neural/glial antigen 2  (NG2) 
promoter, which is transcribed in oligodendrocytes, VSMC and pericytes.215 Therefore 
D  Conclusion 
 
 
 
71 
reporter mice express red fluorescent protein in those three cell types. Since a 
differentiation of the cell types in vivo is challenging expression characteristics have to 
be further identified in histological slices. The information that is obtained by histological 
staining can then be used for the interpretation of in vivo data. A detailed analysis of the 
same ROI in vivo and histologically is not possible with currently available experimental 
techniques. In the future whole brain clearing in combination with light sheet microscopy 
227 will help to investigate fluorescence expression patterns in situ and histologically.  
In the NG2 DsRed mouse line the differentiation between VSMC and pericytes is 
especially challenging because both cell types express essentially the same cell 
markers and none of the commercially available antibodies is specific for either cell 
type.159 In order to solve this issue we investigated a combination of cell characteristics: 
The first criterion was the localization of the cell along the vascular tree. VSMC 
confluently cover arteries and arterioles whereas pericytes are located solitary close to 
capillaries and capillary bifurcations.157 The second criterion was cell morphology. 
Smooth muscle cells are wrapping the vessel whereas pericytes are spindle shaped 
cells with long primary and short secondary processes. The cell localization and their 
morphology can be assessed by in vivo microscopy. The third criterion was the 
expression of different antigens that were examined by immunohistological staining. 
Platelet derived growth factor receptor ß (PDGF Rß) was used as a rather specific 
marker for pericytes and αSMA as a marker for VSMC. A combination of localization, 
morphology and marker expression allows the differentiation of VSMC and pericytes in 
the NG2 DsRed mouse line.  
Vessel diameter after SAH in pericyte reporter mice was investigated to make a 
potential pericyte or VSMC contraction visible. Superficial artery and arteriole spasm co-
localized with VSMC, indicating that VSMC are inducing formation of microvasospasm. 
However the finding that VSMC co-localize with sites where vasospasm occur does not 
yet prove that they are actively inducing vessel constrictions. In order to show VSMC 
contraction along superficial microvasospasm functional Ca2+ imaging will have to be 
performed.  
In the microcirculation pericyte localization was investigated in relation to capillary 
narrowing after SAH. Vessel narrowing specifically at sites where pericytes are present 
would indicate that pericytes are constricting and thereby reducing the capillary 
lumen.203 However no co-localization of capillary narrowing and pericyte location was 
detected. Therefore pericytes do not seem to be involved in capillary narrowing after 
SAH. This finding is not in line with previous publications on pericyte constriction in 
ischemic conditions.198, 203 Yemisci et. al. show that pericyte constrict upon oxidative 
stress and narrow capillary lumen thereby hampering blood flow.203 Hall et. al. report 
similar reactions of pericytes to oxygen glucose deprivation suggesting that pericytes 
die in rigor mortis upon ischemia.198 The conflicting results are probably caused by the 
different pathophysiology of SAH and ischemic stroke. Presumably energy depletion is 
much more pronounced in the ischemic core of a focal stroke as compared to cortical 
perfusion deficits after SAH. A more severe metabolic derangement presumably 
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induces more widespread pericyte dysfunction. Furthermore the studies that 
investigated the role of pericytes in ischemic conditions have some limitations.  The 
publication which shows pericytes constriction upon oxidative stress is a histological 
study. Whether capillary diameter can be investigated in histological sections is 
debatable.228 The publication suggesting that pericytes die in “rigor mortis” was 
performed in ex vivo brain slice preparations. However the condition of oxygen glucose 
deprivation reveals differences to cerebral ischemia in vivo. Aspects like blood flow and 
circulation, systemic inflammatory responses and edema formation cannot be mimicked 
in brain slice cultures. In this setup the cerebral pathophysiology of stroke is narrowed 
down to oxygen and energy depletion. Therefore studies on pericyte constriction in 
ischemic condition will have to be confirmed by making use of functional imaging to 
clarify the role of pericytes in ischemia. 
 
As the sole localization of a cell type in relation to vessel spasm is a rather weak 
indicator for its involvement in the pathophysiology we went one step further and 
performed functional Ca2+ imaging after SAH in vivo. A transgenic mouse line 
expressing the Ca2+ sensor TN-XXL under the promotor of chicken β-actin was used.216 
We expected expression in cerebral perivascular cells as described from a GFP β-actin 
reporter mouse.199 Therefore we aimed to visualize the activation status of pericytes 
and VSMC before and after SAH. In the CAG TN-XXL mouse line however the 
cerebrovascular expression of the Ca2+ sensor is largely confined to endothelial cells. 
With this mouse line changes in endothelial intracellular Ca2+ concentration may be 
specifically addressed. Since investigations on Ca2+ changes in endothelial cells have to 
date primarily been performed in cell culture,229, 230 our approach allows for the first time 
to investigate cerebral endothelial Ca2+ signaling in vivo. Measurements in the baseline 
condition and after sham surgery revealed robust Ca2+ concentrations in endothelial 
cells. No bleaching or leaking of the sensor from endothelial cells was observed. After 
SAH the ratio change indicates decreased Ca2+ levels in endothelial cells. This finding 
can be explained by decreased blood flow velocity in cerebral vessels after SAH. Shear 
stress, which is imposed on endothelial cells by blood flow, has an impact on the 
activation status of endothelial cells. High blood flow velocity induces high endothelial 
Ca2+ concentration.218 High Ca2+ concentration in endothelial cells in turn activates 
endothelial nitric oxide synthase (eNOS), which leads to increased nitric oxide (NO) 
production and vasodilation. After SAH the activity of eNOS is reduced, leading to 
decreased NO levels and subsequent vasoconstriction. Low endothelial Ca2+ 
concentration could therefore be a trigger for endothelial dysfunction after SAH. 
The CAG TN-XXL mouse line provides an excellent tool to further investigate functional 
Ca2+ concentration in endothelial cells in response to changes of neural activity or 
cerebral blood flow. These investigations might further elucidate neurovascular coupling 
and blood flow dynamics in the brain, principle mechanisms which are important in 
health and disease. 
 
D  Conclusion 
 
 
 
73 
4. Summary 
 
With our imaging setup we were able to investigate the cerebral microcirculation after 
SAH in detail. New vessel constriction patterns and reduced blood flow velocity in 
superficial arteries were identified. Perfused vessel volume was significantly reduced 
after SAH, indicating parenchymal ischemia. Leukocyte plugging occurred in capillaries, 
but low numbers made significant contribution to perfusion deficits after SAH unlikely. 
Microvasospasm of superficial arteries occurred at locations where VSMC confluently 
cover the vessel, however capillary narrowing did not co-localize with pericyte location. 
This finding supports the assumption that pericytes do not play a major role in the 
formation of early ischemia after SAH. Furthermore neither migration of pericytes nor 
cell death were observed acutely after SAH. Free intracellular Ca2+ concentration in 
endothelial cells was reduced after SAH. The reduction of endothelial Ca2+ may explain 
reduced NO levels and thereby endothelial dysfunction and vasoconstriction. Taken 
together these results further characterize early cerebral ischemia after SAH and 
suggest new key players in the formation of vessel spasm. 
  
5. Outlook 
 
This thesis investigates different aspects on the formation of microvasospasm after 
SAH but cannot provide a definite answer on the pathomechanism. It gives rise to more 
questions that may be addressed in this context. 
 
Perfusion deficits of the brain parenchyma early after SAH should be investigated in 
more detail. Especially the distribution of perfusion deficits in different brain structures 
and its severity close to the bleeding site will be interesting to examine. The current 
experimental setup allows perfusion measurement in the cortex, either by laser Doppler 
flowmetry on the temporal bone or by assessment of perfused vessel volume with two-
photon microscopy. The technique of autoradiography determines absolute perfusion 
values in whole brain slices.231 If this technique is applied after SAH induction, early 
deficits in parenchymal perfusion will be detectable. The knowledge, which brain areas 
are severely undersupplied after SAH, if applicable to patients, will help to explain 
neurological deficits early after SAH. 
 
Our data on the involvement of pericytes in the early pathophysiology after SAH 
indicate that pericytes are not causative for early cerebral ischemia. However this 
finding should be confirmed by investigations in a pericyte deficient mouse model. Mice 
that are devoid of pericytes, e.g. PDGF Rß full knockouts die during gestation.183 
Therefore pericyte deficient mouse models have been created that exhibit a reduced 
number of pericytes. Heterozygous PDGF Rβ knockouts exhibit only 35% functional 
pericytes.173 Another frequently used mouse model for the investigation of pericytes is 
the PDGF b ret/ret mouse line which specifically lack the retention motive of PDGF b. As 
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the retention motive is important for the creation of a steep gradient of PDGF b around 
the vessel, a knockout leads to wider diffusion of PDGF b. The steep gradient, however, 
is needed for the proper attachment of pericytes to the endothelium. PDGF b ret/ret 
knockout mice exhibit pericytes that are not associated to vessels and are therefore not 
functional.183 A broad phenotype can primarily be seen in retinal and renal vasculature 
although also BBB disruption has been reported.183 We intend to investigate the PDGF 
b ret/ret mouse line to confirm that pericytes are indeed not involved in the formation of 
early cerebral ischemia after SAH. 
 
More studies especially on the functional changes after SAH will have to be conducted 
in order to gain comprehensive insight into the processes of early ischemia after SAH. 
Because always an interplay of different cerebral cell types is defining a 
pathophysiology we plan to investigate functional changes in the whole neurovascular 
unit after SAH. Only a broad approach can ensure to elucidate the interplay between 
cells and the consequences for each cell type. As mentioned above functional in vivo 
investigations of specific cell types are not easy to perform. Maybe in the future mice 
that express Ca2+ dyes under cell-specific promotors will be available. Such functional 
transgenic mouse model would enable researchers to investigate, similarly to the CAG 
TN-XXL strain for endothelial cells, the different components of the neurovascular unit. 
In the pathology of vasospasm after SAH VSMC will be the first target because strong 
indication on their contribution to the formation of vessel spasm exists. Functional Ca2+ 
imaging in these cells will reveal the dynamics and extent of VSMC activation and 
constriction after SAH.  Another important target for functional imaging is the crosstalk 
between neurons and the vasculature. The cells of the neurovascular unit that are 
probably involved in this communication are astrocytes and specifically astrocytic 
endfeet. It has already been shown in brain slices that Ca2+ sparks increase in 
frequency and intensity after SAH.146 In this context it will be interesting to carry out a 
detailed characterization of neuronal activity after SAH. A specific targeting of neurons 
with Ca2+ probes may be performed by selective transfer by adenovirus.232 Viral labeling 
of cells allows making use of the newest generation of Ca2+ sensitive dyes with a high 
specificity. Further functional in vivo investigation will elucidate the communication 
between astrocytes, neurons and the vasculature in health and disease. Only when the 
crosstalk between the involved cell types is comprehensively understood the 
identification of reasonable therapeutic targets for early ischemia after SAH will be 
possible.  
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